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1Title: The Image Biomarker Standardization Initiative: standardized quantitative radiomics 
for high-throughput image-based phenotyping
Article Type: Original research
Summary statement:
The Image Biomarker Standardization Initiative validated consensus-based reference values 
for 169 radiomics features, thus enabling calibration and verification of radiomics software.
Key results:
● 25 research teams found agreement for calculation of 169 radiomics features derived 
from a digital phantom and a human lung cancer on CT scan.
● Of these 169 candidate radiomics features, good to excellent reproducibility was 
achieved for 167 radiomics features using MRI, 18F-FDG PET and CT images 
obtained in 51 patients with soft-tissue sarcoma.
Keywords
Radiomics, standardization, software quality assurance, quantitative image analysis, 
reporting guidelines
Abbreviations
2D: Two-dimensional
3D: Three-dimensional
GTV: gross tumor volume
IBSI: Image Biomarker Standardization Initiative
ICC: intra-class correlation coefficient
ROI: region of interest
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2Abstract
Background: Radiomic features may quantify characteristics present in medical imaging. 
However, the lack of standardized definitions and validated reference values have hampered 
clinical usage.
Purpose: To standardize a set of 174 radiomic features.
Materials and Methods: Radiomic features were assessed in three phases. In phase I, 487 
features were derived from the basic set of 174 features. Twenty-five research teams with 
unique radiomics software implementations computed feature values directly from a digital 
phantom, without any additional image processing. In phase II, fifteen teams computed 
values for 1347 derived features using a CT image of a patient with lung cancer and 
predefined image processing configurations. In both phases, consensus among the teams 
on the validity of tentative reference values was measured through the frequency of the 
modal value: <3 matches: weak; 3-5: moderate; 6-9: strong; ≥10 very strong.
In the final phase (III), a public dataset of multi-modality imaging (CT, 18F-FDG-PET and T1-
weighted MR) from 51 patients with soft-tissue sarcoma was used to prospectively assess 
reproducibility of standardized features..
Results: Consensus on reference values was initially weak for 232/302 (76.8%; phase I) 
and 703/1075 (65.4%; phase II) features. At the final iteration, weak consensus remained for 
only 2/487 (0.4%; phase I) and 19/1347 (1.4%; phase II) features, and strong or better 
consensus was achieved for 463/487 (95.1%; phase I) and 1220/1347 (90.6%; phase II). 
Overall, 169/174 features were standardized in the first two phases. In the final validation 
phase (III), almost all standardized features could be excellently reproduced: CT:166/169 
features; PET:164/169 and MRI: 164/169.
Conclusion: A set of 169 radiomics features was standardized, which enables verification 
and calibration of different radiomics software.
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3Introduction
Personalization of medicine is driven by the need to accurately diagnose and define suitable 
treatments for patients (1). Medical imaging is a potential source of biomarkers, by providing 
a macroscopic view of tissues of interest (2). Imaging has the advantage of being non-
invasive, readily available in clinical care, and repeatable (3,4). 
Radiomics extracts features from medical imaging that quantify its phenotypic characteristics 
in an automated, high-throughput manner (5). Such features may prognosticate, predict 
treatment outcomes, and assess tissue malignancy in cancer research (6–9). In 
neuroscience, features may detect Alzheimer’s disease (10) and diagnose autism spectrum 
disorder (11).
Despite the growing clinical interest in radiomics, published studies have been difficult to 
reproduce and validate (5,9,12–14). Even for the same image, two different software 
implementations will often produce different feature values. This is because standardized 
definitions of radiomics features with verifiable reference values are lacking, and the image 
processing schemes required to compute features are not implemented consistently (15–
18). This is exacerbated by reporting that is insufficiently detailed to enable studies and 
findings to be reproduced (19).
We formed the Image Biomarker Standardization Initiative (IBSI) to address these 
challenges by fulfilling the following objectives: I) to establish a nomenclature and definitions 
for commonly used radiomics features; II) to establish a general radiomics image processing 
scheme for calculation of features from imaging; III) to provide datasets and associated 
reference values for verification and calibration of software implementations for image 
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4processing and feature computation; and IV) to provide a set of reporting guidelines for 
studies involving radiomic analyses.
Materials and Methods
Study Design
We divided the current work into three phases (Figure 1). The first two phases focussed on 
iterative standardization and were followed by a third validation phase. In phase I, the main 
objective was to standardize radiomics feature definitions and define reference values, in the 
absence of any additional image processing. In phase II, we defined a general radiomics 
image processing scheme and obtained reference values for features under different image 
processing configurations. In phase III, we assessed if the standardization conducted in the 
previous phases resulted in reproducible feature values for a validation dataset.
Research teams
We invited teams of radiomics researchers to collaborate in the IBSI. Participation was 
voluntary and open for the duration of the study. Teams were eligible if they:
● developed their own software for image processing and feature computation;
● could participate in any phase of the study.
Radiomics features
We defined set of 174 radiomics features (Table 1). This set consisted of features that are 
commonly used to quantify the morphology, first-order statistical aspects, and spatial 
relationships between voxels (texture) in regions of interest in 3D images. Texture features 
have additional, feature-specific parameters that are required to compute them, which 
increased the number of computed features beyond 174 (supplementary note A). All feature 
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5definitions are provided in chapter 3 of the IBSI reference manual (online supplemental 
materials).
General radiomics image processing scheme
We defined a general radiomics image processing scheme based on descriptions in the 
literature (3,6,17,20). The scheme contained the main processing steps required for 
computation of features from a reconstructed image, and is depicted in Figure 2. A full 
description of these image processing steps may be found in chapter 2 of the IBSI reference 
manual (online supplemental materials).
Datasets
Each phase used a different dataset. In phase I, we designed a small 80-voxel three-
dimensional digital phantom with a 74-voxel region of interest (ROI) mask to facilitate the 
process of establishing reference values for features, without involving image processing.
In phase II we used a publicly available CT image of a lung cancer patient. The 
accompanying segmentation of the gross tumor volume (GTV) was used as the ROI (21).
The validation dataset that was used in phase III consisted of a cohort of 51 patients with 
soft-tissue sarcoma and multi-modality imaging (co-registered CT, 18F-FDG PET and T1-
weighted MRI) from the Cancer Imaging Archive (20,22,23). Each image was accompanied 
by a GTV segmentation, which was used as the ROI. PET and MRI were centrally pre-
processed (supplementary note B) to ensure that SUV-conversion and bias-field correction 
steps did not affect validation.
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6Defining consensus on the validity of feature reference values
In the first two phases, research teams computed feature values from the ROI in the 
associated image dataset directly (phase I) and according to predefined image processing 
parameters (phase II; supplementary note B). All of the most recent values submitted by 
each team were collected and limited to three significant digits. Then, we used the mode of 
the submitted values for each feature as a tentative reference value. 
We quantified the level of consensus on the validity of a tentative reference value for each 
feature using two measures:
1. The number of research teams that submitted a value that matched the tentative 
reference value within a tolerance margin (supplementary note C).
2. The above number divided by the total number of research teams that submitted a 
value.
Four consensus levels were assigned based on the first consensus measure: <3: weak; 3-5: 
moderate; 6-9: strong; ≥10: very strong. The second measure assessed the stability of the 
consensus. We considered a tentative reference value for a feature to be valid only if it had 
at least moderate consensus and it was reproduced by an absolute majority (exceeding 
50%) of the contributing research teams.
Iterative standardization process
In the first two phases, we iteratively refined consensus on the validity of feature reference 
values. This iterative process simultaneously served to standardize feature definitions and 
the general radiomics image processing scheme (24). At the start of the iterative process we 
provided initial definitions for features (phase I) and the general radiomics image processing 
scheme (phase II) in a working document. For phase I, we moreover manually calculated 
mathematically exact reference values for all but morphological features to verify values 
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7produced by the research teams. For phase II, we defined five different image processing 
configurations (A-E) that covered a range of image processing parameters and methods that 
are commonly used in radiomics studies (supplementary note B).
After producing the initial working document, we asked the research teams to compute 
feature values from the ROI in the digital phantom (phase I) and from the ROI in the lung 
cancer CT image after image processing according to the different predefined image 
processing configurations (phase II). Feature values were collected and processed to 
analyze the consensus on the validity of tentative reference values. The results were then 
made available to all teams at an average interval of 4 weeks. The study leader would also 
contact the teams with feedback after comparing their submitted feature values with the 
mathematically exact values (phase I only) and with feature values obtained by other teams 
(phases I and II). The research teams provided feedback in the form of questions and 
suggestions concerning the standardization of radiomics software and regarding descriptions 
in the working document. The working document was regularly updated as a result. Teams 
would then make changes to their software based on the results of the analysis and 
feedback from the study leader.
The two iterative phases were staggered to make it easier to separate differences and errors 
related to feature computation from those related to image processing. The initial 
contributions from phase I were analyzed in September 2016. We initiated phase II after 
moderate or better consensus on the validity of reference values was achieved for at least 
70% of the features, i.e. time point 6 (January 2017). Initial contributions for phase II were 
analyzed at time point 10 (April 2017). Afterwards, phases I and II were concurrent. We 
halted the iterative standardization process at time point 25 (March 2019) after we attained 
strong or better consensus on validity of reference values for over 90% of the features in 
both phases I and II. The overall timeline of the study is summarized in supplementary note 
D.
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8Validation
After the standardization process finished, we asked the research teams to compute 174 
features from the GTV in each of the images in the soft-tissue sarcoma validation cohort 
using a realistic, pre-defined image processing configuration (supplementary note B). The 
computed feature values were collected and processed centrally, as follows. First, for each 
team we removed any feature that was not standardized by their software. To do so, we 
compared the reference values of the respective feature with the values that the team 
obtained from the CT image of the lung cancer patient under image processing 
configurations C, D and E (as in phase II). If a value did not match its reference value, the 
feature was not used. The reproducibility of remaining, standardized features was 
subsequently assessed using a two-way random effects, single rater, absolute agreement 
intraclass correlation coefficient (ICC) (25). Using the lower boundary of the 95% confidence 
interval of the ICC value (ICC-CI-low) (26), reproducibility of each feature was assigned to 
one of the following categories, after Koo and Li (27): poor: ICC-CI-low<0.50; moderate: 
0.50≤ICC-CI-low< 0.75; good: 0.75≤ICC-CI-low<0.90; excellent: 0.90≤ICC-CI-low.
Results
Characteristics of the participating research teams
Twenty-five teams contributed to the IBSI (Figure 3; supplementary note E). Fifteen teams 
contributed to both standardization phases, and nine teams contributed to the validation 
phase. One team retired because they switched to software developed by another team. 
Five teams implemented 95% or more of the defined features. Nine teams were able to 
compute features for all image processing configurations in phase II (supplementary note F).
Two top-level institutions (e.g. university) provided more than one participating team of 
researchers, i.e. the University Medical Center Groningen and INSERM Brest with three and 
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reference values. Moderate, strong or very strong consensus on the validity of the reference 
values was based on teams from at least three, five and eight different top-level institutions, 
respectively (see supplementary note G).
MATLAB (n=10), C++ (n=7) and Python (n=5) were the most popular programming 
languages. No language dependency was found: consensus of all features with a moderate 
or better consensus on the validity of their reference values were based on multiple 
programming languages (see supplementary note H).
Consensus on validity of feature reference values
Consensus on the validity of feature reference values improved over the course of the study, 
as shown in Figure 4 and Table 2. Initially, only weak consensus existed for the majority of 
features: 232/302 (76.8%) and 703/1075 (65.4%) for phase I and II, respectively.
At the final analysis time point, the number of features with a weak consensus had 
decreased to 2/487 (0.4%) for phase I and 19/1347 (1.4%) for phase II. The remaining 
features with weak consensus on the validity of their (tentative) reference values were the 
area and volume densities of the oriented minimum bounding box and the minimum volume 
enclosing ellipsoid (see supplementary note I). We were unable to standardize the complex 
algorithms that are required to compute the oriented minimum bounding box and minimum 
volume enclosing ellipsoid. Therefore, the above features should not be regarded as 
standardized.
As shown in Table 2, strong or better consensus could be established for 463/487 (95.1%) 
and 1220/1347 (90.6%) features in phases I and II respectively. None of these features were 
found to be unstable. In phase II, 2/108 (1.9%) features with moderate consensus were 
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unstable. Both were derived from the same feature: the area under the curve of the intensity-
volume histogram. Hence, we do not consider this feature to be standardized.
The most commonly implemented features were mean, skewness, excess kurtosis and 
minimum of the intensity-based statistics family. These were implemented by 23/24 research 
teams. No feature was implemented by all teams (see supplementary note J).
Reproducibility of standardized features
We were able to find stable reference values with moderate or better consensus for 169/174 
features. In the validation phase, most of these features could be reproduced well (Figure 5, 
supplementary note K). Excellent reproducibility was found for 166/174, 164/174 and 
164/174 features for CT, PET and MRI, respectively, and good reproducibility was found for 
1/174, 3/174 and 3/174 features. For each modality, 2/174 features had unknown 
reproducibility, indicating that they were computed by less than two teams during validation. 
These features were Moran’s I index and Geary’s C measure, which although they were 
standardized, are expensive to compute. The remaining 5/174 features could not be 
standardized during the first two phases and were not assessed during validation.
Discussion
In this study, the Image Biomarker Standardization Initiative produced and validated a set of 
consensus-based reference values for radiomics features. Twenty-five research teams were 
able to standardize 169/174 features, which were subsequently shown to have good to 
excellent reproducibility in a validation data set.
With the completion of the current work, compliance with the IBSI standard can be checked 
for any radiomics software, as follows: 
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● Use the software to compute features using the digital phantom. Compare the 
resulting values against the reference values that are found in the IBSI reference 
manual and the compliance check spreadsheet created for this purpose (online 
supplemental materials). Investigate any difference. Subsequently, resolve the 
differences or explain them, e.g. the use of kurtosis instead of excess kurtosis.
● Afterwards, repeat the above with the CT dataset used in this study and one or more 
of the image processing configurations that were used in phase II.
Initial consensus on the validity of reference values for many features was weak, which 
means that teams obtained different values for the same feature. This mirrors findings 
reported elsewhere (15–18). Several notable causes of deviations were identified – for 
example, differences in interpolation, morphological representation of the ROI and 
nomenclature differences – and subsequently resolved (supplementary note L). In effect, we 
cross-calibrated radiomics software implementations.
The demonstrated lack of initial correspondence between teams carries a clinical implication. 
Software implementations of seemingly well-defined mathematical formulas can vary greatly 
in the numeric results they produce. Clinical radiologists that are using advanced image 
analysis workstations should be aware of this, think critically about comparing results 
produced by different workstations and demand more details and validation studies from the 
vendors of those workstations.
Findings from most radiomics studies have not been translated into clinical practice, and 
require external retrospective and prospective validation in clinical trials (2,28). The IBSI, in 
addition to the presented work, has defined reporting guidelines (see supplemental 
materials) that indicate the elements that should be reported to facilitate this process. 
However, we refrained from creating a comprehensive recommendation on how to perform a 
good radiomics analysis, for several reasons. First, such recommendations will necessarily 
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have to be modality-specific and possibly entity-specific (29,30). The related specific 
evidence for the effect of particular parameters, e.g. the choice of interpolation algorithm, is 
far from complete. Secondly, recommendations or guidelines regarding parts of the 
radiomics analysis are already covered comprehensively elsewhere, e.g. by the TRIPOD 
statement on diagnostic and prognostic modelling (31). Certainly, the image processing 
configurations used in phase II are not intended for general use, as their primary aim was to 
cover a range of different methods. Only the configurations defined for the validation dataset 
resemble a realistic set of parameters given the entity and the imaging modalities.
The current work has several limitations. First, our aim was to lay a foundation for 
standardized computation of radiomics features. To this end, we sought to standardize 174 
commonly used features, and obtain reference values using image processing methods that 
radiomics researchers most commonly employ. To keep the scope manageable, many other 
features such as fractals and image filters were not assessed (32), important modality-
specific image processing steps were not benchmarked, and uncommon image processing 
methods were not investigated either. This is a serious limitation, and one that the IBSI is 
currently addressing.
Despite the fact that standardized feature computation is an important step towards 
reproducible radiomics, the need for standardization and harmonization related to image 
acquisition, reconstruction and segmentation remains, as these constitute additional sources 
of variability in radiomics studies. Because of this variability, features that can be reproduced 
from the same image using standardized radiomics software, may nevertheless lack 
reproducibility in multi-centric or multi-scanner settings (14,19,33). We did not address these 
issues here as their comprehensive harmonization is the ongoing focus of other consortia 
and professional societies (2). Other approaches have also been proposed to deal with 
these issues, such as the reduction of cohort effects on radiomics features using statistical 
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methods (34) and application of artificial intelligence to convert between reconstruction 
kernels in CT imaging (35).
In conclusion, the Image Biomarker Standardization Initiative was able to produce and 
validate reference values for radiomics features. These reference values enable verification 
of radiomics software, which will increase reproducibility of radiomics studies and facilitate 
clinical translation of radiomics.
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Figure Legends
Figure 1. Study overview.
The workflow in a typical radiomics analysis starts with acquisition and reconstruction of a 
medical image. Subsequently, the image is segmented to define regions of interest. 
Afterwards, radiomics software is used to process the image, and compute features that 
characterize a region of interest. We focused on standardizing the image processing and 
feature computation steps. Standardization was performed within two iterative phases. In 
phase I, we used a specially designed digital phantom to obtain reference values for 
radiomics features directly. Subsequently, in phase II, a publicly available CT image of a 
lung cancer patient was used to obtain reference values for features under predefined 
configurations of a standardized general radiomics image processing scheme. 
Standardization of image processing and feature computation steps in radiomics software 
was prospectively validated during phase III by assessing reproducibility of standardized 
features in a publicly available multi-modality patient cohort of 51 patients with soft-tissue 
sarcoma.
Figure 2. The general radiomics image processing scheme for computing radiomics 
features.
Image processing starts with reconstructed images. These images are processed through 
several optional steps: data conversion (e.g. conversion to Standardized Uptake Values), 
image post-acquisition processing (e.g. image denoising) and image interpolation. The 
region of interest (ROI) is either created automatically during the segmentation step or an 
existing ROI is retrieved. The ROI is then interpolated as well, and intensity and 
morphological masks are created as copies. The intensity mask may optionally be re-
segmented based on intensity values to improve comparability of intensity ranges across a 
cohort. Radiomics features are then computed from the image masked by the ROI and its 
immediate neighborhood (local intensity features) or the ROI itself (all others). Image 
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intensities are moreover discretized prior to computation of features from the intensity 
histogram (IH), intensity-volume histogram (IVH), grey level co-occurrence matrix (GLCM), 
grey level run length matrix (GLRLM), grey level size zone matrix (GLSZM), grey level 
distance zone matrix (GLDZM), neighborhood grey tone difference matrix (NGTDM) and 
neighboring grey level dependence matrix (NGLDM) families. All processing steps from 
image interpolation to the computation of radiomics features were evaluated in this study.
Figure 3. Participation and radiomics feature coverage by research teams.
(A) Graph showing the number of research teams at each analysis time point during the two 
phases of the iterative standardization process. Teams computed features without prior 
image processing (phase I), and after image processing (phase II), with the aim of finding 
reference values for a feature. Consensus on the validity of reference values was assessed 
at each of the analysis time points, the time between which was variable (arbitrary unit; arb. 
unit). (B) Graph showing the final coverage of radiomics features implemented by each team 
in phase I, as well as the team’s ability to reproduce the reference value of a feature. We 
were unable to obtain reliable reference values for five features (no ref. value). The teams 
are listed in supplementary note E.
Figure 4. Iterative development of consensus on the validity of reference values for 
radiomics features.
We tried to find reliable reference values for radiomics features in an iterative 
standardization process. In phase I features were computed without prior image processing, 
whereas in phase II features were assessed after image processing with five predefined 
configurations (conf. A-E; supplementary note B). The panels show the overall development 
of consensus on the validity of (tentative) reference values in phases I and II (A) and the 
development of consensus in phase II, split by image processing configuration (B). 
Consensus on the validity of a reference value is based on the number of research teams 
that produce the same value for a feature: weak < 3; moderate: 3-5; strong: 6-9; very strong: 
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≥ 10. We analyzed consensus at each of the analysis time points, the time between which 
was variable (arbitrary unit; arb. unit). New features were included at time points 5 and 22, 
causing an apparent decrease in consensus. For phase II, we first analyzed consensus at 
time point 10. Image processing configurations C and D were altered after time point 16. 
Configuration E was altered after revising the re-segmentation processing step at time point 
22. See supplementary note D for more information regarding the timeline.
Figure 5. Reproducibility of standardized radiomics features.
We assessed reproducibility of 169 standardized features on a validation cohort of 51 
patients with soft-tissue sarcoma and multi-modality imaging (CT, 18F-FDG-PET, T1-
weighted MR; shown as CT, PET and MRI), based on the feature values computed by 
research teams. We assigned each feature to a reproducibility category based on the lower 
boundary of the 95% confidence interval of the two-way random effects, single rater, 
absolute agreement intraclass correlation coefficient of the feature: poor: < 0.50; moderate: 
0.50-0.75; good: 0.75-0.90; excellent: ≥ 0.90. Five features could not be standardized in this 
study. Two features with unknown reproducibility were computed by fewer than two teams 
during validation.
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Tables
Table 1. Overview of included radiomics features.
Feature family Base 
definition
Number of features
Phase I Phase II 
conf. A-B 
(2D)
Phase II 
conf. C-E 
(3D)
Phase III
Morphology 29 29 29 29 29
Local intensity 2 2 2 2 2
Intensity-based statistics 18 18 18 18 18
Intensity histogram (IH) 23 23 23 23 23
Intensity-volume histogram (IVH) 7 7 7 7 7
Grey level co-occurrence matrix (GLCM)a 25 150 100 50 25
Grey level run-length matrix (GLRLM)a 16 96 64 32 16
Grey level size zone matrix (GLSZM)a 16 48 32 16 16
Grey level distance zone matrix (GLDZM)a 16 48 32 16 16
Neighborhood grey tone difference matrix (NGTDM)a 5 15 10 5 5
Neighboring grey level dependence matrix (NGLDM)a 17 51 34 17 17
Total 174  487 351 215 174
Note: A set of 174 radiomics features was standardized and validated in three phases. In 
phase I features were computed without any prior image processing. In phase II features 
were computed after image processing with five predefined configurations (conf. A-E; 
supplementary note B). In the final phase III we assessed the reproducibility of features 
standardized in phases I and II.
a Texture features have additional parameters that are required for their calculation, which 
increased the number of computed features (supplementary note A).
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Table 2. Consensus on the validity of reference values of radiomics features at initial 
and final analysis time points for phases I and II.
Consensus level
total weak moderate strong very 
strong 
 ≥ mod. ≥ strong
n unstable n unstable n unstable n unstable n n n
Initial analysis time point phase I
phase I 302 147 (48.7) 232 (76.8) 133 (57.3) 48 (15.9) 12 (25.0) 16 (5.3) 2 (12.5) 6 (2.0) 70 (23.2) 22 (7.3)
Initial analysis time point phase II
phase II 1075 610 (56.7) 703 (65.4) 537 (76.4) 342 (31.8) 73 (21.3) 30 (2.8) 0 (—) 0 (—) 372 (34.6) 30 (2.8)
configuration A 215 28 (13.0) 114 (53.0) 26 (22.8) 98 (45.6) 2 (2.0) 3 (1.4) 0 (—) 0 (—) 101 (47.0) 3 (1.4)
configuration B 215 149 (69.3) 188 (87.4) 149 (79.3) 27 (12.6) 0 (—) 0 (—) 0 (—) 0 (—) 27 (12.6) 0 (—)
configuration C 215 97 (45.1) 87 (40.5) 72 (82.8) 112 (52.1) 25 (22.3) 16 (7.4) 0 (—) 0 (—) 128 (59.5) 16 (7.4)
configuration D 215 162 (75.3) 141 (65.6) 129 (91.5) 63 (29.3) 33 (52.4) 11 (5.1) 0 (—) 0 (—) 74 (34.4) 11 (5.1)
configuration E 215 174 (80.9) 173 (80.5) 161 (93.1) 42 (19.5) 13 (31.0) 0 (—) 0 (—) 0 (—) 42 (19.5) 0 (—)
Final analysis time point phase  I & II
phase I 487 2 (0.4) 2 (0.4) 2 (100.0) 22 (4.5) 0 (—) 234 (48.0) 0 (—) 229 (47.0) 485 (99.6) 463 (95.1)
phase II 1347 20 (1.5) 19 (1.4) 18 (94.7) 108 (8.0) 2 (1.9) 1152 (85.5) 0 (—) 68 (5.0) 1328 (98.6) 1220 (90.6)
configuration A 351 4 (1.1) 4 (1.1) 3 (75.0) 22 (6.3) 1 (4.5) 307 (87.5) 0 (—) 18 (5.1) 347 (98.9) 325 (92.6)
configuration B 351 5 (1.4) 4 (1.1) 4 (100.0) 24 (6.8) 1 (4.2) 317 (90.3) 0 (—) 6 (1.7) 347 (98.9) 323 (92.0)
configuration C 215 4 (1.9) 4 (1.9) 4 (100.0) 9 (4.2) 0 (—) 171 (79.5) 0 (—) 31 (14.4) 211 (98.1) 202 (94.0)
configuration D 215 4 (1.9) 4 (1.9) 4 (100.0) 6 (2.8) 0 (—) 192 (89.3) 0 (—) 13 (6.0) 211 (98.1) 205 (95.3)
configuration E 215 3 (1.4) 3 (1.4) 3 (100.0) 47 (21.9) 0 (—) 165 (76.7) 0 (—) 0 (—) 212 (98.6) 165 (76.7)
Note: Reference values of radiomics features were iteratively obtained in two phases. In 
phase I features were computed without prior image processing, whereas in phase II 
features were computed after image processing with five predefined configurations (conf. A-
E; supplementary note B). Consensus on the validity of a reference value was based on the 
number of research teams that produced the same value: weak < 3; moderate (mod.): 3-5; 
strong: 6-9; very strong: ≥ 10. For each consensus level, the number and percentage of 
features is shown (“n”) together with the number and percentage of these features for which 
the consensus was only carried by a minority of teams (≤ 50%; “unstable”). Features with 
very strong consensus were never unstable, and the respective column was omitted. The 
number of features increased between the initial and final time points due to adding new 
features and computing features with additional feature-specific parameters (supplementary 
notes A, D).
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Supplemental Materials
Supplementary notes
Contains additional information concerning the methodology and results of the current work.
IBSI reference manual
Contains extensive descriptions of the image processing scheme (chapter 2), the feature 
definitions (chapter 3), reporting guidelines and feature nomenclature (chapter 4), and a 
description of the datasets with instructions on how to use them (chapter 5).
Compliance check spreadsheet
The compliance check spreadsheet provides the reference values in an accessible manner 
and enables calibration of software for computing radiomics features. Feature values can be 
inserted and will automatically be checked against the reference values obtained in this 
study.
IBSI guidelines for reporting on radiomics studies
A stand-alone copy of the checklist for reporting on radiomics studies.
Datasets
The datasets and corresponding segmentation masks are available in DICOM and NIfTI 
formats and may be found on the IBSI website: https://theibsi.github.io.
Analysis scripts
Analysis scripts (in R) are available on GitHub: 
https://github.com/theibsi/ibsi_1_data_analysis
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 fig 1 Study overview. The workflow in a typical radiomics analysis starts with acquisition and reconstruction 
of a medical image. Subsequently, the image is segmented to define regions of interest. Afterwards, 
radiomics software is used to process the image, and compute features that characterize a region of 
interest. We focused on standardizing the image processing and feature computation steps. Standardization 
was performed within two iterative phases. In phase I, we used a specially designed digital phantom to 
obtain reference values for radiomics features directly. Subsequently, in phase II, a publicly available CT 
image of a lung cancer patient was used to obtain reference values for features under predefined 
configurations of a standardized general radiomics image processing scheme. Standardization of image 
processing and feature computation steps in radiomics software was prospectively validated during phase III 
by assessing reproducibility of standardized features in a publicly available multi-modality patient cohort of 
51 patients with soft-tissue sarcoma. 
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 fig 2 The general radiomics image processing scheme for computing radiomics features. Image processing 
starts with reconstructed images. These images are processed through several optional steps: data 
conversion (e.g. conversion to Standardized Uptake Values), image post-acquisition processing (e.g. image 
denoising) and image interpolation. The region of interest (ROI) is either created automatically during the 
segmentation step or an existing ROI is retrieved. The ROI is then interpolated as well, and intensity and 
morphological masks are created as copies. The intensity mask may optionally be re-segmented based on 
intensity values to improve comparability of intensity ranges across a cohort. Radiomics features are then 
computed from the image masked by the ROI and its immediate neighborhood (local intensity features) or 
the ROI itself (all others). 
138x165mm (300 x 300 DPI) 
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 fig 3 Participation and radiomics feature coverage by research teams. (A) Graph showing the number of 
research teams at each analysis time point during the two phases of the iterative standardization process. 
Teams computed features without prior image processing (phase I), and after image processing (phase II), 
with the aim of finding reference values for a feature. Consensus on the validity of reference values was 
assessed at each of the analysis time points, the time between which was variable (arbitrary unit; arb. unit). 
(B) Graph showing the final coverage of radiomics features implemented by each team in phase I, as well as 
the team’s ability to reproduce the reference value of a feature. We were unable to obtain reliable reference 
values for five features (no ref. value). The teams are listed in supplementary note E. 
119x88mm (300 x 300 DPI) 
Page 30 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d v
ers
ion
 20
20
-01
-07
 fig 4 Iterative development of consensus on the validity of reference values for radiomics features. We tried 
to find reliable reference values for radiomics features in an iterative standardization process. In phase I 
features were computed without prior image processing, whereas in phase II features were assessed after 
image processing with five predefined configurations (conf. A-E; supplementary note B). The panels show 
the overall development of consensus on the validity of (tentative) reference values in phases I and II (A) 
and the development of consensus in phase II, split by image processing configuration (B). Consensus on 
the validity of a reference value is based on the number of research teams that produce the same value for 
a feature: weak < 3; moderate: 3-5; strong: 6-9; very strong: ≥ 10. We analyzed consensus at each of the 
analysis time points, the time between which was variable (arbitrary unit; arb. unit). New features were 
included at time points 5 and 22, causing an apparent decrease in consensus. For phase II, we first analyzed 
consensus at time point 10. Image processing configurations C and D were altered after time point 16. 
Configuration E was altered after revising the re-segmentation processing step at time point 22. See 
supplementary note D for more information regarding the timeline. 
121x87mm (300 x 300 DPI) 
Page 31 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pt
d v
ers
i n
 20
20
-01
-07
 fig 5 Reproducibility of standardized radiomics features. We assessed reproducibility of 169 standardized 
features on a validation cohort of 51 patients with soft-tissue sarcoma and multi-modality imaging (CT, 18F-
FDG-PET, T1-weighted MR; shown as CT, PET and MRI), based on the feature values computed by research 
teams. We assigned each feature to a reproducibility category based on the lower boundary of the 95% 
confidence interval of the two-way random effects, single rater, absolute agreement intraclass correlation 
coefficient of the feature: poor: < 0.50; moderate: 0.50-0.75; good: 0.75-0.90; excellent: ≥ 0.90. Five 
features could not be standardized in this study. Two features with unknown reproducibility were computed 
by fewer than two teams during validation. 
57x57mm (300 x 300 DPI) 
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The Image Biomarker Standardization Initiative: 
standardized quantitative radiomics for high-throughput 
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1Supplementary note A: Features and feature-specific parameters
Some features require specific parameters to compute them, as is detailed in chapter 3 and again 
summarised in chapter 4 of the IBSI reference manual. In case default parameters exist (e.g. grey 
level co-occurrence matrix (GLCM) distance equal to 1), these were used. This leaves feature 
aggregation parameters for all texture features and intensity and volume fraction parameters for 
intensity-volume histogram (IVH) features.
IVH features were computed at 10% and 90% intensity and volume fractions, leading to a static 
increase of two features over the number of base definitions found in the reference manual. In the 
main manuscript, these features are already accounted for.
Texture features are computed from texture matrices. Such matrices may be computed along 
directions in a grid (2D) or volume (3D), or using 2D or 3D neighborhoods. Grey level co-occurrence 
and run length matrices (GLRLM) are directional, whereas grey level size zone (GLSZM), distance 
zone (GLDZM), neighborhood grey tone difference (NGTDM) and neighboring grey level dependence 
(NGLDM) matrices are based on neighborhoods. Aggregation methods can be specified according to 
whether matrices are directional or neighborhood.
For directional matrices six different aggregation methods can be designed. Four of these methods 
pertain to 2D analysis, and the remaining two to 3D analysis. This effectively multiplies the number of 
texture features by a factor four, two and six for 2D, 3D and combined analyses, respectively.
For neighborhood-based matrices three different aggregation methods can be designed, two of which 
pertain to 2D analysis and one to 3D analysis. The number of features is then multiplied by a factor of 
two or three for 2D and combined analyses, respectively.
Page 34 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d v
ers
ion
 20
20
-01
-07
2Supplementary note B: Image processing configurations
Phase I — Finding reference values for radiomics features
In phase I, we attempted to obtain reference values for radiomics features in the absence of image 
processing. Hence, image processing settings were functionally absent. However, if some standard 
settings were required to be set, we used the following:
Parameter Configuration
slice-wise (2D) or single volume (3D) 2D and 3D
interpolation none
re-segmentation none
discretisation none or FBS: 1 or FBN: 6
Table N1: Image processing parameters for the digital phantom used in phase I. The configuration 
does not alter the image or its mask in any way.
Phase II — Finding reference values for radiomics features using a standardized 
image processing scheme
In phase II, we attempted to find reference values for radiomics features with image processing, which 
is a more realistic scenario. We therefore defined the following five configurations that cover several 
commonly used parameter settings. These configurations do not necessarily represent recommended 
settings.
Parameter Config. A Config. B Config. C Config. D Config. E
slice-wise (2D) or single volume (3D) 2D 2D 3D 3D 3D
interpolation none yes yes yes yes
  resampled voxel spacing (mm) 2 × 2 (axial) 2 × 2 × 2 2 × 2 × 2 2 × 2 × 2
  interpolation method bilinear trilinear trilinear tricubic spline
  intensity rounding nearest integer nearest integer nearest integer nearest integer
  ROI interpolation method bilinear trilinear trilinear trilinear
  ROI partial mask volume 0.5 0.5 0.5 0.5
re-segmentation
  range (HU) [-500, 400] [-500, 400] [-1000, 400] none [-1000, 400]
  outlier filtering none none none 3σ 3σ
discretisation
  texture and IH FBS: 25 HU FBN: 32 bins FBS: 25 HU FBN: 32 bins FBN: 32 bins
  IVH none none FBS: 2.5 HU none FBN: 1000 bins
texture
  GLCM, NGTDM, NGLDM distance 1 1 1 1 1
  GLSZM, GLDZM linkage distance 1 1 1 1 1
  NGLDM coarseness 0.0 0.0 0.0 0.0 0.0
Table N2: Image processing parameter configurations for finding reference values for radiomics 
features using the lung cancer CT image. ROI: region of interest; HU: Hounsfield Unit; IH: intensity 
histogram; IVH: intensity-volume histogram; FBS: fixed bin size; FBN: fixed bin number; GLCM: grey 
level co-occurrence matrix; NGTDM: neighborhood grey tone difference matrix; NGLDM: 
neighbouring grey level dependence matrix; GLSZM: grey level size zone matrix; GLDZM: grey level 
distance zone matrix.
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3Phase III — Validation
In phase III, the research teams validated the software implementation of standardized features by 
assessing reproducibility of standardized radiomics features against a new dataset consisting of CT, 
18F-FDG-PET and T1-weighted MR imaging, with a predefined image processing configuration. This 
dataset was preprocessed to ensure that image processing steps that were not investigated during 
phase II could not affect reproducibility.
Therefore, prior to validation, PET imaging was converted to body-weight corrected SUV, cropped 50 
mm around the GTV ROI and exported to DICOM and NIfTI formats.
T1-weighted MR images were bias-field corrected using the N4 algorithm (1) implemented in ITK 
5.0.1, using 3 fitting levels, a maximum of 100 iterations at each level and a convergence threshold of 
0.001. Subsequently, the images were normalized on subcutaneous fat intensity to increase 
comparability between the different MR images, as follows. The 95th percentile of the intensities 
within the patient mask (i.e. tissue voxels) were used to indicate subcutaneous fat. This was verified 
for all patients. Afterwards, the image intensities were normalized through linear mapping so that 1000 
corresponds to the subcutaneous fat intensity in the original image, and 0 corresponds to 0 in the 
original image. Next, the images were cropped 50 mm around the GTV ROI. The values in the 
normalized image were then converted to integers prior to export as DICOM and NIfTI formats.
CT images did not undergo any pre-processing and were exported directly to DICOM and NIfTI 
formats after cropping to 50 mm around the GTV ROI.
The exported datasets were then shared with the research teams, who extracted feature values 
according to a modality-specific configuration. These configurations are shown below. Note that these 
configurations are not necessarily recommended, but are well-adjusted to the available imaging data.
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4Parameter CT configuration PET configuration MR configuration
slice-wise (2D) or single volume (3D) 3D 3D 3D
interpolation yes yes yes
  resampled voxel spacing (mm) 1 × 1 × 1 3 × 3 × 3 1 × 1 × 1
  interpolation method tricubic spline tricubic spline tricubic spline
  intensity rounding nearest integer a
  ROI interpolation method trilinear trilinear trilinear
  ROI partial mask volume 0.5 0.5 0.5
re-segmentation
  range (HU) [-200, 200] [0, ∞) b [0, ∞) b
  outlier filtering none none none
discretisation
  texture and IH FBS: 10 HU FBS: 0.25 SUV FBS: 0.05
  IVH none a FBS: 0.10 SUV FBS: 0.01
texture c
  GLCM, GLRLM aggregation 3D with averaging 3D with averaging 3D with averaging
  GLSZM, GLDZM, NGTDM, NGLDM 
aggregation
3D 3D 3D
  GLCM, NGTDM, NGLDM distance 1 1 1
  GLSZM, GLDZM linkage distance 1 1 1
  NGLDM coarseness 0.0 0.0 0.0
Table N3 Image processing parameter configurations for the validation data sets. ROI: region of 
interest; HU: Hounsfield Unit; SUV: standardized uptake volume. IH: intensity histogram; IVH: 
intensity-volume histogram; FBS: fixed bin size; FBN: fixed bin number; GLCM: grey level co-
occurrence matrix; NGTDM: neighborhood grey tone difference matrix; NGLDM: neighbouring grey 
level dependence matrix; GLSZM: grey level size zone matrix; GLDZM: grey level distance zone 
matrix.
a Default settings.
b Actual resegmentation is not required. All intensity values fall within this range.
c No distance weighting is performed. The default distance norms are used.
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5Supplementary note C: Tolerance margins
Different algorithm choices, rounding errors and other issues may lead to minor deviations from the 
reference value of radiomics features. These do not constitute errors or lack of compliance, but should 
be accounted for regardless. Different features display varying sensitivity to minor perturbations. 
Some, such as the mean intensity are relatively stable, but others may vary to a greater extent.
Tolerance was determined for the morphological features in phase I and for all features in phase II. In 
phase I, tolerance was required since different volume meshing algorithms were found to produce 
slightly different meshes. Differences in meshes lead to deviations in volume and surface area which 
are propagated into other morphological features. A narrow tolerance of 0.5% of the reference value 
was used. For other features no tolerance margin was allowed, as these followed mathematically 
exact definitions.
In phase II, image processing may lead to minor deviations in feature values. As the response of 
radiomics features to such perturbations varies and cannot be easily translated into a relative 
tolerance, we perturbed the image and region of interest mask prior to the interpolation step by 
rotation and translation in the xy-plane with growth and shrinkage of the region of interest (2):
● Rotation: from -15° to 15° in 5° steps.
● Translation: permutations of 0.0, 0.25, 0.50 and 0.75 times the voxel spacing in the xy-plane.
● Growth and shrinkage: 2 mm growth, original size and 2 mm shrinkage.
Thus 336 values were produced for each feature using the MIRP software (3). The tolerance margin 
is then set to 5% of the interquartile range.
A separate spreadsheet is appended to the main manuscript. This file contains the reference values 
and the tolerance margins of all radiomics features obtained from the digital phantom and those 
obtained from the lung cancer CT image under five image processing configurations.
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6Supplementary note D: Study timeline
The first IBSI installment spans the period from June 2016 to October 2019. An overview of the 
project timeline is provided in Table N4 below.
Date Time Description
8 June 2016 — A draft study proposal was formulated and shared with initial participants.
30 June 2016 — Final study proposal was formulated and shared. The digital phantom was created and 
shared, together with the first version of the work document. Phase I was initiated.
14 September 2016 1 Initial contributions for the digital phantom are shared.
9 October 2016 2 Contributions were updated and shared.
24 October 2016 3 The IBSI was presented at the Radiomics meeting in Clearwater, Florida, USA. Contributions 
were updated and shared.
6 December 2016 4 Contributions were updated and shared.
8 December 2016 — A major update to the work document was shared with the research teams. Several new 
features were added, based on requests. Volume and surface area features were re-defined 
based on meshing algorithms. The general radiomics image processing scheme was drafted.
23 December 2016 5 Contributions were updated and shared. Sections of the work document were posted to arXiv 
to provide a reference for radiomics features. The dataset for phase II was identified.
24 January 2017 6 Contributions were updated and shared.
30 January 2017 — The image processing configurations were defined. Phase II was initiated.
10 February 2017 7 Contributions were updated and shared.
24 February 2017 8 Contributions were updated and shared.
10 March 2017 9 Contributions were updated and shared.
14 April 2017 10 Contributions were updated and shared, including initial results for phase II.
21 April 17 — Segmentation of the RT structure set and image interpolation were identified as major 
sources of divergence.
6 May 2017 — Meeting of several IBSI teams during the ESTRO 36 conference, where an electronic poster 
for IBSI was presented.
19 May 2017 11 Contributions were updated and shared. The description of interpolation is made more 
precise, and the concept of morphological and intensity ROI masks was introduced.
26 June 2017 12 Contributions were updated and shared.
24 July 2017 13 Contributions were updated and shared. The arXiv document was updated with a new image 
processing section.
11 August 2017 14 Contributions were updated and shared.
31 August 2017 15 Contributions were updated and shared.
11 October 2017 16 Contributions were updated and shared. First use of tolerance in determining reference 
values.
23 October 2017 — Progress of IBSI was presented at the Radiomics meeting in Clearwater, Florida, USA.
16 November 2017 17 Contributions were updated and shared. The arXiv document was updated with a guidelines 
section, as well as all prior changes to sections of the IBSI work document included in the 
arXiv document. Configurations C and D were revised. Moreover, the section describing the 
Intensity-Volume Histogram was extensively revised.
4 December 2017 18 Contributions were updated and shared.
5 January 2018 19 Contributions were updated and shared.
17 January 2018 — A draft version of the manuscript was prepared and shared with several co-authors.
1 February 2018 — A revised version of the manuscript was shared with all co-authors.
13 February 2018 20 Late contributions were updated and shared.
20 February 2018 — Manuscript was sent out for peer-review.
22 August 2018 — Manuscript was returned with reviewer comments.
30 August 2018 — Discretisation definitions were updated.
1 October 2018 21 Contributions were updated and shared. The arXiv document was updated to include the 
improvements to discretisation.
5 October 2018 — Configuration E was updated to reflect new re-segmentation definitions. 2.5D texture features 
were added.
16 October 2018
22 November 2018
—
22
Progress of IBSI was presented at the Radiomics meeting in Clearwater, Florida, USA.
Contributions were updated and shared.
4 January 2019 23 Contributions were updated and shared.
1 February 2019 24 Contributions were updated.
1 March 2019 25 Contributions were updated and shared. Consensus on the validity of reference values was 
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7found to be sufficient to halt the iterative standardization process.
4 April 2019 — A completely revised version of the manuscript was shared with all co-authors.
16 May 2019 — The arXiv document was updated to include tables of reference values.
23 May 2019 — Manuscript was sent out for peer-review.
6 August 2019 — Review comments were received.
4 September 2019 — The validation phase (III) was started using new datasets deriving from CT, PET and MR 
imaging.
14 October 2019 — All validation results were collected and parsed.
22 October 2019 — The revised manuscript was submitted for peer-review.
9 December 2019 — A second revision was submitted.
Table N1: Overview of the project timeline with main events. The time points may be found in figures 
and tables in this study.
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8Supplementary note E: Research team information
In total, 25 research teams voluntarily participated in the IBSI. Details are found in Table N5 below. 
Participation criteria were as follows:
● A team developed their own software for image processing and feature computation.
● A team would participate in at least one phase of the study.
The initial set of teams was invited directly as they were either present at the ESTRO radiomics 
workshop in 2016, were known to be interested, or had done some early work in the direction of 
standardization. Teams then also referred to other potentially interested teams of researchers, who 
then joined as well. Beyond the initial set, most teams joined after learning of the IBSI at conferences 
or workshops, through colleagues, or after encountering the arXiv preprint. Several open-source 
developers were directly invited (e.g. LifeX). Recruitment was open at any point during the study.
Figure N1: Details concerning the teams and their software implementations. (A) Graph showing the 
number of teams involved in each phase. One team retired because they switched to software 
developed by another team. (B) Source code and software availability, and (C) the main programming 
languages of the research teams..
As shown in Figure N1, eleven of the twenty-five teams developed publicly available software 
implementations: McGill (4–6), MITK (7), Pyradiomics (8), CERR (9), QuantImage (10), QIFE (11), 
RaCaT (12), CaPTk (13,14), LIFEx (15), SERA (16) and MIRP (3). The remainder used in-house 
software.
Team Institution Main developer First entry Language Availability
Brest (BCOM) INSERM Brest Taman Upadhaya 1 C++ in-house
Brest (MaCha) INSERM Brest Marie-Charlotte
Desseroit, Baptiste 
Laurent
1 C++ in-house
Gemelli Fondazione Policlinico Universitario 
Agostino Gemelli
Jacopo Lenkowicz 1 R in-house
LUMC Leiden University Medical Center 
(LUMC), VU University Medical Center
Floris H.P. van Velden, 
Ronald Boellaard
1 IDL in-house
McGill McGill University Martin Vallières 1 MATLAB open source1
MITK German Cancer Research Center 
(DKFZ)
Michael Götz, Fabian
Isensee, Jonas Scherer
1 C++ open source2
Moffitt Moffitt Cancer Center Mahmoud A. Abdalah 1 C++ in-house
NKIa the Netherlands Cancer Institute (NKI) Cuong Viet Dinh 1 C++ in-house
MIRP OncoRay – National Center for 
Radiation Research in Oncology
Alex Zwanenburg, 
Stefan Leger
1 Python open source3
Tuebingen University of Tübingen 1 Python in-house
1 https://github.com/mvallieres/radiomics-develop
2 http://mitk.org
3 https://github.com/oncoray/mirp
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9UMCG (van Dijk) University Medical Center Groningen 
(UMCG)
Lisanne V. van Dijk 1 MATLAB in-house
USZ University of Zurich Marta Bogowicz 1 Python in-house
MAASTRO Maastricht University Medical Centre+ Ralph T.H. Leijenaar 2 MATLAB in-house
Cardiff Cardiff University Philip Whybra 4 MATLAB in-house
UMCG (Beukinga) University Medical Center Groningen 
(UMCG)
Roelof J. Beukinga 8 MATLAB in-house
Pyradiomics the Netherlands Cancer Institute (NKI), 
Maastricht University, Dana-Farber 
Cancer Institute
Joost van Griethuysen, 
Andriy Fedorov
9 Python open source4
UCSF University of California, San Francisco 
(UCSF)
Olivier Morin 10 Python in-house
CERR Memorial Sloan Kettering Cancer 
Center
Aditya Apte 11 MATLAB open source5
SERA Johns Hopkins University Saeed Ashrafinia 12 MATLAB open source6
QuantImage University of Applied Sciences 
Western Switzerland (HES-SO)
Adrien Depeursinge, 
Vincent Andrearczyk
18 MATLAB web-based7
QIFE Stanford University Sebastian Echegaray, 
Sarah Mattonen
20 MATLAB open source8
RaCaT University Medical Center Groningen 
(UMCG)
Elisabeth Pfaehler 21 C++ open source9
CaPTk University of Pennsylvania Sarthak Pati, Sung Min 
Ha
21 C++ open source10
LIFEx Université Paris Saclay Christophe Nioche 21 Java freeware11
KCL King’s College London Muhammad Siddique 22 MATLAB in-house
Table N5: Details regarding the participating research teams. The institution is the main institution at 
which the developers worked, which were either universities, university medical centers or research 
institutions. The main developers were primarily responsible for developing, testing and adapting 
source code during the course of the project. The first entry is the time point at which the team’s 
contribution was first incorporated.
a This research team retired after stopping development of their software and switching to the 
software developed by another participant (pyradiomics).
4 https://github.com/Radiomics/pyradiomics
5 https://github.com/cerr/CERR
6 https://github.com/ashrafinia/SERA
7 https://radiomics.hevs.ch/
8 https://github.com/riipl/3d_qifp
9 https://github.com/ellipfaehlerUMCG/RaCat
10 https://github.com/CBICA/CaPTk
11 https://www.lifexsoft.org/
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Supplementary note F: Coverage of features per research team
Research teams were not required to implement every feature and support all image processing 
options. This led to a feature coverage that varied between teams, which is shown in Figure N2 
below. Nine teams implemented >50% of the features, and five teams implemented > 95% of the 
features.
Figure N2: Feature coverage of each research team at the final analysis time point for phases I and 
II. Features were extracted from the digital phantom (phase I) and from a CT lung cancer image using 
image processing configurations A-E (phase II). “no ref. value” indicates that there was no consensus 
on a reference value of a feature, i.e. the number of matching values produced by the teams was < 3, 
or matching values were produced by ≤50% of contributing teams. “Deviating” indicates that a feature 
was implemented, but deviated from the reference value. “Matching” indicates that a feature was 
implemented and the reference value could be reproduced by the team. The number of features is 
different for each dataset due to different availability of texture matrix aggregation methods: 487 
(digital phantom), 351 (configurations A, B), and 215 (configurations C-E).
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Supplementary note G: Number of unique institutions and consensus
Research teams that are part of the same institution may potentially share the same code. We did not 
find any evidence to support this. Four teams shared an institution and developed their software using 
the same language. Concurrent submissions from these teams showed differences in feature values, 
which is evidence against using the same code. However, even if the same code was being used by 
multiple teams within an institution, the effect on consensus is weak, as shown below.
As shown in Table N6 below, the minimum number of unique top-level institutions with matching 
values was:
● 3 for features with moderate consensus.
● 5 for features with strong consensus.
● 8 for features with very strong consensus.
Note that consensus on the validity of reference values is based on the number of research teams 
that reproduced the reference value: 3: weak; 3-5: moderate; 6-9: strong; ≥ 10 very strong. Hence the 
same number of unique top-level institutions may appear for multiple consensus levels.
Consensus level Unique top-level institutions Number of features
weak 1 16
weak 2 5
moderate 3 20
moderate 4 56
moderate 5 54
strong 5 224
strong 6 559
strong 7 390
strong 8 199
strong 9 14
very strong 8 2
very strong 9 126
very strong 10 19
very strong 11 27
very strong 12 30
very strong 13 27
very strong 14 30
very strong 15 10
very strong 16 16
very strong 17 2
very strong 18 4
very strong 19 2
very strong 20 2
Table N6: The number of unique top-level institutions for features grouped by the level of consensus 
on the validity of their reference values.
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Supplementary note H: Number of unique programming languages and 
consensus
Though the research teams developed independent software, the underlying routines may be based 
on standard implementations. For example, most, if not all, languages have a standard 
implementation for the mean function. Reference values should be based on more than one language 
to avoid potential reliance on a single standard implementation. As shown in Table N7 below, this is 
the case for all features with moderate or better consensus.
Note that consensus on the validity of reference values is based on the number of research teams 
that reproduced the reference value: 3: weak; 3-5: moderate; 6-9: strong; ≥ 10 very strong. Hence the 
same number of unique programming languages may appear for multiple consensus levels.
Consensus level Unique languages Number of features
weak 1 16
weak 2 5
moderate 2 7
moderate 3 123
strong 3 934
strong 4 393
strong 5 59
very strong 3 100
very strong 4 111
very strong 5 81
very strong 6 5
Table N7: The number of unique programming languages for features grouped by the level of 
consensus on the validity of their reference values.
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Supplementary note I: Features with a weak consensus
Moderate or better consensus could not be established for every feature. These features are the 
same across the different data sets, namely the area and volume densities derived from the minimum 
volume enclosing ellipsoid (MVEE) and the oriented minimum bounding box (OMBB). OMBB and 
MVEE both rely on complex algorithmic optimisers that are not commonly implemented. The OMBB 
for the digital phantom is easily determined, as it is the same as the axis-aligned bounding box.
Data set Feature Matches Dissent
digital phantom Area density (MVEE) 1 3
digital phantom Volume density (MVEE) 1 3
configuration A Area under the IVH curve 3 3
configuration A Area density (MVEE) 2 1
configuration A Area density (OMBB) 1 3
configuration A Volume density (MVEE) 1 2
configuration A Volume density (OMBB) 1 3
configuration B Area under the IVH curve 3 3
configuration B Area density (MVEE) 1 2
configuration B Area density (OMBB) 1 3
configuration B Volume density (MVEE) 1 3
configuration B Volume density (OMBB) 1 3
configuration C Area density (MVEE) 1 2
configuration C Area density (OMBB) 1 3
configuration C Volume density (MVEE) 1 3
configuration C Volume density (OMBB) 2 2
configuration D Area density (MVEE) 1 2
configuration D Area density (OMBB) 2 2
configuration D Volume density (MVEE) 1 2
configuration D Volume density (OMBB) 2 2
configuration E Volume density (MVEE) 1 3
configuration E Area density (MVEE) 1 4
configuration E Volume density (OMBB) 2 2
Table N8: Features with a weak level of consensus. These are features describing morphological 
features based on the oriented minimum bounding box (OMBB) and the minimum volume enclosing 
ellipsoid (MVEE). The number of matches and the number of dissenting research teams is shown.
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Supplementary note J: Detailed information regarding feature 
implementations
Table N9 below contains information concerning each feature at its initial introduction and after the 
final iteration:
● The number of research teams that were able to reproduce the tentative reference value of a 
feature.
● The number of teams that contributed a value.
● The total number of teams.
First entry Final entry
matching implem. total matching implem. total
Morphological features
Volume (mesh) 8 10 12 11 12 24
Volume (voxel counting) 13 13 17 21 21 24
Surface area (mesh) 1 11 12 11 12 24
Surface to volume ratio 1 11 12 10 12 24
Compactness 1 1 11 12 9 11 24
Compactness 2 1 11 12 9 11 24
Spherical disproportion 1 11 12 9 11 24
Sphericity 1 11 12 10 12 24
Asphericity 0 9 12 8 11 24
Centre of mass shift 7 9 12 15 15 24
Maximum 3D diameter 4 9 12 8 12 24
Major axis length 2 10 12 14 17 24
Minor axis length 2 9 12 11 17 24
Least axis length 2 9 12 11 17 24
Elongation 6 9 12 14 19 24
Flatness 6 9 12 13 18 24
Volume density (AABB) 2 3 14 6 8 24
Area density (AABB) 1 3 14 7 8 24
Volume density (OMBB) 2 2 14 3 3 24
Area density (OMBB) 2 2 14 3 3 24
Volume density (AEE) 2 2 14 5 7 24
Area density (AEE) 2 2 14 5 6 24
Volume density (MVEE) 1 2 14 1 4 24
Area density (MVEE) 1 2 14 1 4 24
Volume density (convex hull) 2 2 14 6 7 24
Area density (convex hull) 2 2 14 7 7 24
Integrated intensity 3 3 14 5 8 24
Moran's I index 2 2 14 7 7 24
Geary's C measure 2 2 14 7 7 24
Local intensity features
Local intensity peak 1 2 14 8 8 24
Global intensity peak 1 2 14 6 7 24
Intensity-based statistical features
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Mean 12 12 12 23 23 24
Variance 6 12 12 14 22 24
Skewness 10 12 12 21 23 24
(Excess) kurtosis 6 12 12 20 23 24
Median 9 10 12 20 20 24
Minimum 11 11 12 23 23 24
10th percentile 9 9 12 18 18 24
90th percentile 5 9 12 12 18 24
Maximum 11 11 12 22 22 24
Interquartile range 8 9 12 20 20 24
Range 10 10 12 19 19 24
Mean absolute deviation 9 10 12 19 19 24
Robust mean absolute deviation 7 9 12 17 17 24
Median absolute deviation 2 2 14 12 12 24
Coefficient of variation 1 2 14 12 14 24
Quartile coefficient of dispersion 2 2 14 12 12 24
Energy 10 10 12 17 17 24
Root mean square 9 9 12 17 17 24
Intensity histogram features
Mean 4 4 14 13 13 24
Variance 2 4 14 9 12 24
Skewness 4 4 14 12 13 24
Kurtosis 3 4 14 12 13 24
Median 3 4 14 11 11 24
Minimum 4 4 14 13 13 24
10th percentile 4 4 14 10 10 24
90th percentile 3 4 14 7 10 24
Maximum 4 4 14 12 12 24
Mode 2 2 14 10 10 24
Interquartile range 3 4 14 11 11 24
Range 4 4 14 11 11 24
Mean absolute deviation 3 4 14 11 11 24
Robust mean absolute deviation 4 4 14 10 10 24
Median absolute deviation 2 2 14 10 10 24
Coefficient of variation 1 2 14 10 10 24
Quartile coefficient of dispersion 2 2 14 10 10 24
Entropy 8 11 12 19 19 24
Uniformity 8 10 12 19 19 24
Maximum histogram gradient 2 2 14 10 10 24
Maximum histogram gradient intensity 2 2 14 8 10 24
Minimum histogram gradient 2 2 14 10 10 24
Minimum histogram gradient intensity 2 2 14 9 10 24
Intensity-volume histogram features
Volume fraction at 10% intensity 2 2 14 10 10 24
Volume fraction at 90% intensity 2 2 14 10 10 24
Intensity at 10% volume 1 2 14 10 10 24
Intensity at 90% volume 1 2 14 10 10 24
Volume fraction difference between 10% and 90% 
intensity
2 2 14 10 10 24
Intensity difference between 10% and 90% volume 2 2 14 10 10 24
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Area under the IVH curve 1 2 14 8 9 24
Co-occurrence matrix (2D, averaged) features
Joint maximum 2 3 12 10 10 24
Joint average 1 3 12 10 10 24
Joint variance 1 3 12 10 10 24
Joint entropy 2 3 12 10 10 24
Difference average 1 3 12 10 10 24
Difference variance 1 3 12 10 10 24
Difference entropy 1 3 12 10 10 24
Sum average 2 3 12 10 10 24
Sum variance 1 3 12 10 10 24
Sum entropy 1 3 12 10 10 24
Angular second moment 2 3 12 10 10 24
Contrast 2 3 12 10 10 24
Dissimilarity 2 3 12 10 10 24
Inverse difference 1 2 12 10 10 24
Normalized inverse difference 1 2 12 10 10 24
Inverse difference moment 1 3 12 10 10 24
Normalized inverse difference moment 2 3 12 10 10 24
Inverse variance 1 2 12 10 10 24
Correlation 1 3 12 10 10 24
Autocorrelation 2 3 12 10 10 24
Cluster tendency 2 3 12 10 10 24
Cluster shade 2 3 12 10 10 24
Cluster prominence 2 3 12 10 10 24
Information correlation 1 1 3 12 10 10 24
Information correlation 2 1 3 12 9 10 24
Co-occurrence matrix (2D, slice-merged) features
Joint maximum 1 1 12 9 9 24
Joint average 1 1 12 9 9 24
Joint variance 1 1 12 9 9 24
Joint entropy 1 1 12 9 9 24
Difference average 1 1 12 9 9 24
Difference variance 1 1 12 9 9 24
Difference entropy 1 1 12 9 9 24
Sum average 1 1 12 9 9 24
Sum variance 1 1 12 9 9 24
Sum entropy 1 1 12 9 9 24
Angular second moment 1 1 12 9 9 24
Contrast 1 1 12 9 9 24
Dissimilarity 1 1 12 9 9 24
Inverse difference 1 1 12 9 9 24
Normalized inverse difference 1 1 12 9 9 24
Inverse difference moment 1 1 12 9 9 24
Normalized inverse difference moment 1 1 12 9 9 24
Inverse variance 1 1 12 9 9 24
Correlation 1 1 12 9 9 24
Autocorrelation 1 1 12 9 9 24
Cluster tendency 1 1 12 9 9 24
Cluster shade 1 1 12 9 9 24
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Cluster prominence 1 1 12 9 9 24
Information correlation 1 1 1 12 9 9 24
Information correlation 2 1 1 12 8 9 24
Co-occurrence matrix (2.5D, direction-merged) features
Joint maximum 4 4 21 8 8 24
Joint average 4 4 21 8 8 24
Joint variance 4 4 21 8 8 24
Joint entropy 4 4 21 8 8 24
Difference average 4 4 21 8 8 24
Difference variance 4 4 21 8 8 24
Difference entropy 4 4 21 8 8 24
Sum average 4 4 21 8 8 24
Sum variance 4 4 21 8 8 24
Sum entropy 4 4 21 8 8 24
Angular second moment 4 4 21 8 8 24
Contrast 4 4 21 8 8 24
Dissimilarity 4 4 21 8 8 24
Inverse difference 4 4 21 8 8 24
Normalized inverse difference 4 4 21 8 8 24
Inverse difference moment 4 4 21 8 8 24
Normalized inverse difference moment 4 4 21 8 8 24
Inverse variance 4 4 21 8 8 24
Correlation 4 4 21 8 8 24
Autocorrelation 4 4 21 8 8 24
Cluster tendency 4 4 21 8 8 24
Cluster shade 4 4 21 8 8 24
Cluster prominence 4 4 21 8 8 24
Information correlation 1 4 4 21 8 8 24
Information correlation 2 4 4 21 7 8 24
Co-occurrence matrix (2.5D, merged) features
Joint maximum 4 4 21 8 8 24
Joint average 4 4 21 8 8 24
Joint variance 4 4 21 8 8 24
Joint entropy 4 4 21 8 8 24
Difference average 4 4 21 8 8 24
Difference variance 4 4 21 8 8 24
Difference entropy 4 4 21 8 8 24
Sum average 4 4 21 8 8 24
Sum variance 4 4 21 8 8 24
Sum entropy 4 4 21 8 8 24
Angular second moment 4 4 21 8 8 24
Contrast 4 4 21 8 8 24
Dissimilarity 4 4 21 8 8 24
Inverse difference 4 4 21 8 8 24
Normalized inverse difference 4 4 21 8 8 24
Inverse difference moment 4 4 21 8 8 24
Normalized inverse difference moment 4 4 21 8 8 24
Inverse variance 4 4 21 8 8 24
Correlation 4 4 21 8 8 24
Autocorrelation 4 4 21 8 8 24
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Cluster tendency 4 4 21 8 8 24
Cluster shade 4 4 21 8 8 24
Cluster prominence 4 4 21 8 8 24
Information correlation 1 4 4 21 8 8 24
Information correlation 2 4 4 21 7 8 24
Co-occurrence matrix (3D, averaged) features
Joint maximum 2 6 12 15 15 24
Joint average 2 5 12 14 15 24
Joint variance 1 6 12 13 15 24
Joint entropy 3 6 12 17 18 24
Difference average 2 5 12 14 14 24
Difference variance 2 6 12 15 15 24
Difference entropy 3 7 12 15 15 24
Sum average 2 7 12 15 15 24
Sum variance 2 7 12 15 15 24
Sum entropy 4 7 12 15 16 24
Angular second moment 2 8 12 18 18 24
Contrast 2 8 12 18 19 24
Dissimilarity 2 7 12 16 16 24
Inverse difference 1 6 12 16 16 24
Normalized inverse difference 1 6 12 14 14 24
Inverse difference moment 1 8 12 16 16 24
Normalized inverse difference moment 1 6 12 15 15 24
Inverse variance 1 6 12 14 14 24
Correlation 2 7 12 16 19 24
Autocorrelation 2 7 12 14 14 24
Cluster tendency 2 6 12 14 14 24
Cluster shade 2 8 12 16 17 24
Cluster prominence 2 8 12 16 16 24
Information correlation 1 1 7 12 14 14 24
Information correlation 2 1 7 12 14 14 24
Co-occurrence matrix (3D, merged) features
Joint maximum 2 4 12 15 15 24
Joint average 2 4 12 15 15 24
Joint variance 2 4 12 15 15 24
Joint entropy 2 4 12 16 16 24
Difference average 2 4 12 14 15 24
Difference variance 2 4 12 14 15 24
Difference entropy 2 4 12 15 15 24
Sum average 2 4 12 15 15 24
Sum variance 2 4 12 14 15 24
Sum entropy 2 4 12 15 15 24
Angular second moment 2 4 12 16 16 24
Contrast 2 4 12 15 16 24
Dissimilarity 2 4 12 15 15 24
Inverse difference 2 4 12 15 15 24
Normalized inverse difference 2 4 12 15 15 24
Inverse difference moment 2 4 12 16 16 24
Normalized inverse difference moment 2 4 12 15 15 24
Inverse variance 2 4 12 15 15 24
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Correlation 2 4 12 15 16 24
Autocorrelation 2 4 12 15 15 24
Cluster tendency 2 4 12 15 15 24
Cluster shade 2 4 12 16 16 24
Cluster prominence 3 4 12 15 16 24
Information correlation 1 2 4 12 14 15 24
Information correlation 2 1 4 12 15 15 24
Run length matrix (2D, averaged) features
Short runs emphasis 1 2 12 10 10 24
Long runs emphasis 1 2 12 10 10 24
Low grey level run emphasis 1 2 12 10 10 24
High grey level run emphasis 1 2 12 10 10 24
Short run low grey level emphasis 1 2 12 10 10 24
Short run high grey level emphasis 1 2 12 10 10 24
Long run low grey level emphasis 1 2 12 10 10 24
Long run high grey level emphasis 1 2 12 10 10 24
Grey level non-uniformity 1 2 12 10 10 24
Normalized grey level non-uniformity 1 1 12 10 10 24
Run length non-uniformity 1 2 12 10 10 24
Normalized run length non-uniformity 1 1 12 10 10 24
Run percentage 1 2 12 10 10 24
Grey level variance 1 2 12 10 10 24
Run length variance 1 2 12 10 10 24
Run entropy 1 2 12 10 10 24
Run length matrix (2D, slice-merged) features
Short runs emphasis 1 1 12 9 9 24
Long runs emphasis 1 1 12 9 9 24
Low grey level run emphasis 1 1 12 9 9 24
High grey level run emphasis 1 1 12 9 9 24
Short run low grey level emphasis 1 1 12 9 9 24
Short run high grey level emphasis 1 1 12 9 9 24
Long run low grey level emphasis 1 1 12 9 9 24
Long run high grey level emphasis 1 1 12 9 9 24
Grey level non-uniformity 1 1 12 9 9 24
Normalized grey level non-uniformity 1 1 12 9 9 24
Run length non-uniformity 1 1 12 9 9 24
Normalized run length non-uniformity 1 1 12 9 9 24
Run percentage 1 1 12 7 9 24
Grey level variance 1 1 12 9 9 24
Run length variance 1 1 12 9 9 24
Run entropy 1 1 12 9 9 24
Run length matrix (2.5D, direction-merged) features
Short runs emphasis 3 4 21 8 8 24
Long runs emphasis 3 4 21 8 8 24
Low grey level run emphasis 3 4 21 8 8 24
High grey level run emphasis 3 4 21 8 8 24
Short run low grey level emphasis 3 4 21 8 8 24
Short run high grey level emphasis 3 4 21 8 8 24
Long run low grey level emphasis 3 4 21 8 8 24
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Long run high grey level emphasis 3 4 21 8 8 24
Grey level non-uniformity 3 4 21 8 8 24
Normalized grey level non-uniformity 3 4 21 8 8 24
Run length non-uniformity 3 4 21 8 8 24
Normalized run length non-uniformity 3 4 21 8 8 24
Run percentage 2 4 21 7 8 24
Grey level variance 3 4 21 8 8 24
Run length variance 3 4 21 8 8 24
Run entropy 3 4 21 7 7 24
Run length matrix (2.5D, merged) features
Short runs emphasis 3 4 21 8 8 24
Long runs emphasis 3 4 21 8 8 24
Low grey level run emphasis 3 4 21 8 8 24
High grey level run emphasis 3 4 21 8 8 24
Short run low grey level emphasis 3 4 21 8 8 24
Short run high grey level emphasis 3 4 21 8 8 24
Long run low grey level emphasis 3 4 21 8 8 24
Long run high grey level emphasis 3 4 21 8 8 24
Grey level non-uniformity 3 4 21 8 8 24
Normalized grey level non-uniformity 3 4 21 8 8 24
Run length non-uniformity 3 4 21 8 8 24
Normalized run length non-uniformity 3 4 21 8 8 24
Run percentage 3 4 21 6 8 24
Grey level variance 2 4 21 7 8 24
Run length variance 2 4 21 7 8 24
Run entropy 2 4 21 6 7 24
Run length matrix (3D, averaged) features
Short runs emphasis 4 8 12 16 17 24
Long runs emphasis 4 8 12 15 17 24
Low grey level run emphasis 4 8 12 17 18 24
High grey level run emphasis 5 8 12 17 18 24
Short run low grey level emphasis 2 8 12 15 18 24
Short run high grey level emphasis 5 8 12 16 18 24
Long run low grey level emphasis 4 8 12 15 18 24
Long run high grey level emphasis 4 8 12 15 18 24
Grey level non-uniformity 5 8 12 16 17 24
Normalized grey level non-uniformity 3 4 12 14 15 24
Run length non-uniformity 2 8 12 16 17 24
Normalized run length non-uniformity 1 4 12 14 15 24
Run percentage 4 7 12 15 16 24
Grey level variance 3 5 12 14 15 24
Run length variance 2 5 12 14 15 24
Run entropy 4 5 12 14 14 24
Run length matrix (3D, merged) features
Short runs emphasis 3 4 12 14 14 24
Long runs emphasis 3 4 12 13 14 24
Low grey level run emphasis 3 4 12 14 14 24
High grey level run emphasis 3 4 12 14 14 24
Short run low grey level emphasis 3 4 12 13 14 24
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Short run high grey level emphasis 3 4 12 14 14 24
Long run low grey level emphasis 3 4 12 13 14 24
Long run high grey level emphasis 4 4 12 13 14 24
Grey level non-uniformity 3 4 12 14 14 24
Normalized grey level non-uniformity 3 3 12 13 13 24
Run length non-uniformity 3 4 12 13 14 24
Normalized run length non-uniformity 3 3 12 13 13 24
Run percentage 3 4 12 12 13 24
Grey level variance 3 4 12 13 13 24
Run length variance 3 4 12 13 13 24
Run entropy 4 4 12 12 12 24
Size zone matrix (2D) features
Small zone emphasis 1 2 12 9 9 24
Large zone emphasis 1 2 12 9 9 24
Low grey level emphasis 1 2 12 9 9 24
High grey level emphasis 1 2 12 9 9 24
Small zone low grey level emphasis 1 2 12 9 9 24
Small zone high grey level emphasis 1 2 12 9 9 24
Large zone low grey level emphasis 1 2 12 9 9 24
Large zone high grey level emphasis 1 2 12 9 9 24
Grey level non-uniformity 2 2 12 9 9 24
Normalized grey level non-uniformity 1 1 12 9 9 24
Zone size non-uniformity 2 2 12 9 9 24
Normalized zone size non-uniformity 1 1 12 9 9 24
Zone percentage 1 2 12 9 9 24
Grey level variance 1 2 12 9 9 24
Zone size variance 1 2 12 9 9 24
Zone size entropy 2 2 12 9 9 24
Size zone matrix (2.5D) features
Small zone emphasis 4 4 21 8 8 24
Large zone emphasis 4 4 21 8 8 24
Low grey level emphasis 4 4 21 8 8 24
High grey level emphasis 4 4 21 8 8 24
Small zone low grey level emphasis 4 4 21 8 8 24
Small zone high grey level emphasis 4 4 21 8 8 24
Large zone low grey level emphasis 4 4 21 8 8 24
Large zone high grey level emphasis 4 4 21 8 8 24
Grey level non-uniformity 4 4 21 8 8 24
Normalized grey level non-uniformity 4 4 21 8 8 24
Zone size non-uniformity 4 4 21 8 8 24
Normalized zone size non-uniformity 4 4 21 8 8 24
Zone percentage 3 4 21 8 8 24
Grey level variance 4 4 21 8 8 24
Zone size variance 4 4 21 8 8 24
Zone size entropy 4 4 21 7 7 24
Size zone matrix (3D) features
Small zone emphasis 5 9 12 19 19 24
Large zone emphasis 6 9 12 19 19 24
Low grey level emphasis 4 9 12 19 19 24
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High grey level emphasis 5 9 12 19 19 24
Small zone low grey level emphasis 3 9 12 19 19 24
Small zone high grey level emphasis 5 9 12 19 19 24
Large zone low grey level emphasis 5 9 12 19 19 24
Large zone high grey level emphasis 5 9 12 17 19 24
Grey level non-uniformity 4 9 12 19 19 24
Normalized grey level non-uniformity 4 6 12 17 17 24
Zone size non-uniformity 6 9 12 19 19 24
Normalized zone size non-uniformity 4 6 12 17 17 24
Zone percentage 4 9 12 19 19 24
Grey level variance 5 7 12 17 17 24
Zone size variance 5 7 12 17 17 24
Zone size entropy 5 7 12 16 16 24
Distance zone matrix (2D) features
Small distance emphasis 1 1 12 7 7 24
Large distance emphasis 1 1 12 7 7 24
Low grey level emphasis 1 1 12 7 7 24
High grey level emphasis 1 1 12 7 7 24
Small distance low grey level emphasis 1 1 12 7 7 24
Small distance high grey level emphasis 1 1 12 7 7 24
Large distance low grey level emphasis 1 1 12 7 7 24
Large distance high grey level emphasis 1 1 12 7 7 24
Grey level non-uniformity 1 1 12 7 7 24
Normalized grey level non-uniformity 1 1 12 7 7 24
Zone distance non-uniformity 1 1 12 7 7 24
Normalized zone distance non-uniformity 1 1 12 7 7 24
Zone percentage 1 1 12 7 7 24
Grey level variance 1 1 12 6 7 24
Zone distance variance 1 1 12 7 7 24
Zone distance entropy 1 1 12 7 7 24
Distance zone matrix (2.5D) features
Small distance emphasis 3 3 21 5 5 24
Large distance emphasis 3 3 21 5 5 24
Low grey level emphasis 3 3 21 5 5 24
High grey level emphasis 3 3 21 5 5 24
Small distance low grey level emphasis 3 3 21 5 5 24
Small distance high grey level emphasis 3 3 21 5 5 24
Large distance low grey level emphasis 3 3 21 5 5 24
Large distance high grey level emphasis 3 3 21 5 5 24
Grey level non-uniformity 3 3 21 5 5 24
Normalized grey level non-uniformity 3 3 21 5 5 24
Zone distance non-uniformity 3 3 21 5 5 24
Normalized zone distance non-uniformity 3 3 21 5 5 24
Zone percentage 2 3 21 3 5 24
Grey level variance 3 3 21 5 5 24
Zone distance variance 3 3 21 5 5 24
Zone distance entropy 3 3 21 5 5 24
Distance zone matrix (3D) features
Small distance emphasis 1 2 12 10 11 24
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Large distance emphasis 1 2 12 10 11 24
Low grey level emphasis 1 2 12 11 11 24
High grey level emphasis 1 2 12 11 11 24
Small distance low grey level emphasis 1 2 12 10 11 24
Small distance high grey level emphasis 1 2 12 10 11 24
Large distance low grey level emphasis 1 2 12 10 11 24
Large distance high grey level emphasis 1 2 12 10 11 24
Grey level non-uniformity 2 2 12 11 11 24
Normalized grey level non-uniformity 2 2 12 11 11 24
Zone distance non-uniformity 1 2 12 10 11 24
Normalized zone distance non-uniformity 1 2 12 10 11 24
Zone percentage 1 1 12 10 11 24
Grey level variance 2 2 12 11 11 24
Zone distance variance 1 2 12 10 11 24
Zone distance entropy 2 2 12 11 11 24
Neighborhood grey tone difference matrix (2D) features
Coarseness 1 2 12 8 8 24
Contrast 1 2 12 8 8 24
Busyness 1 2 12 8 8 24
Complexity 1 2 12 8 8 24
Strength 1 2 12 8 8 24
Neighborhood grey tone difference matrix (2.5D) features
Coarseness 3 4 21 7 7 24
Contrast 3 4 21 7 7 24
Busyness 3 4 21 6 7 24
Complexity 4 4 21 6 7 24
Strength 3 4 21 6 7 24
Neighborhood grey tone difference matrix (3D) features
Coarseness 2 7 12 18 18 24
Contrast 2 7 12 17 18 24
Busyness 2 7 12 16 18 24
Complexity 2 7 12 14 17 24
Strength 2 7 12 14 17 24
Neighboring grey level dependence matrix (2D) features
Low dependence emphasis 1 1 12 7 7 24
High dependence emphasis 1 1 12 7 7 24
Low grey level count emphasis 1 1 12 7 7 24
High grey level count emphasis 1 1 12 7 7 24
Low dependence low grey level emphasis 1 1 12 7 7 24
Low dependence high grey level emphasis 1 1 12 7 7 24
High dependence low grey level emphasis 1 1 12 7 7 24
High dependence high grey level emphasis 1 1 12 7 7 24
Grey level non-uniformity 1 1 12 7 7 24
Normalized grey level non-uniformity 1 1 12 7 7 24
Dependence count non-uniformity 1 1 12 7 7 24
Normalized dependence count non-uniformity 1 1 12 7 7 24
Dependence count percentage 1 1 12 6 6 24
Grey level variance 1 1 12 7 7 24
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Dependence count variance 1 1 12 7 7 24
Dependence count entropy 1 1 12 7 7 24
Dependence count energy 1 1 14 7 7 24
Neighboring grey level dependence matrix (2.5D) features
Low dependence emphasis 4 4 21 7 7 24
High dependence emphasis 4 4 21 7 7 24
Low grey level count emphasis 4 4 21 7 7 24
High grey level count emphasis 4 4 21 7 7 24
Low dependence low grey level emphasis 4 4 21 7 7 24
Low dependence high grey level emphasis 4 4 21 7 7 24
High dependence low grey level emphasis 4 4 21 7 7 24
High dependence high grey level emphasis 4 4 21 7 7 24
Grey level non-uniformity 4 4 21 7 7 24
Normalized grey level non-uniformity 4 4 21 7 7 24
Dependence count non-uniformity 4 4 21 7 7 24
Normalized dependence count non-uniformity 4 4 21 7 7 24
Dependence count percentage 2 2 21 4 5 24
Grey level variance 4 4 21 7 7 24
Dependence count variance 4 4 21 7 7 24
Dependence count entropy 4 4 21 7 7 24
Dependence count energy 3 3 21 6 6 24
Neighboring grey level dependence matrix (3D) features
Low dependence emphasis 1 2 12 12 12 24
High dependence emphasis 1 2 12 12 12 24
Low grey level count emphasis 1 2 12 12 12 24
High grey level count emphasis 1 2 12 12 12 24
Low dependence low grey level emphasis 1 2 12 12 12 24
Low dependence high grey level emphasis 1 2 12 12 12 24
High dependence low grey level emphasis 1 2 12 12 12 24
High dependence high grey level emphasis 1 2 12 12 12 24
Grey level non-uniformity 2 2 12 12 12 24
Normalized grey level non-uniformity 2 2 12 12 12 24
Dependence count non-uniformity 1 2 12 12 12 24
Normalized dependence count non-uniformity 1 2 12 12 12 24
Dependence count percentage 1 1 12 7 7 24
Grey level variance 1 2 12 12 12 24
Dependence count variance 1 2 12 12 12 24
Dependence count entropy 1 2 12 12 12 24
Dependence count energy 2 3 14 10 10 24
Table N9: Details regarding the number of radiomic feature implementations and consensus on the 
validity of tentative reference values at the initial and final time points for the digital phantom in phase 
I. Note that while at the final time point the number of research teams is the same for every feature, 
this is not the case at the initial time point as some radiomics features were introduced later during the 
iterative process.
Page 57 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
c
pte
d v
ers
ion
 20
20
-01
-07
25
Supplementary note K: Feature reproducibility in the validation cohort
For validation, research teams extracted features from CT, 18F-FDG-PET and T1-weighted MR 
images of 51 patients according to the configurations in supplementary note B. Standardization of 
each feature by a team was first assessed by determining whether the team could demonstrate that 
they were able to reproduce the respective reference values under configurations C, D and E 
(established in phase II). If this was the case, the standardized feature was then used to compute a 
two-way random effects, single rater, absolute agreement intraclass correlation coefficient (ICC). 
These ICC values and their 95% confidence intervals are shown in Table N10 below.
CT PET MRI
Morphological features
Volume (mesh) 0.976 [0.964, 0.985] 0.976 [0.964, 0.985] 0.968 [0.952, 0.980]
Volume (voxel counting) 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.999 [0.999, 1.000]
Surface area (mesh) 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.999 [0.999, 0.999]
Surface to volume ratio 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.999 [0.999, 1.000]
Compactness 1 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.995 [0.993, 0.997]
Compactness 2 1.000 [0.999, 1.000] 0.999 [0.999, 1.000] 0.994 [0.990, 0.996]
Spherical disproportion 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.995 [0.993, 0.997]
Sphericity 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.995 [0.992, 0.997]
Asphericity 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.995 [0.992, 0.997]
Centre of mass shift 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.989 [0.984, 0.993]
Maximum 3D diameter 0.997 [0.996, 0.998] 0.997 [0.995, 0.998] 0.990 [0.984, 0.994]
Major axis length 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.993 [0.990, 0.996]
Minor axis length 1.000 [0.999, 1.000] 0.999 [0.999, 1.000] 0.997 [0.996, 0.998]
Least axis length 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 1.000 [1.000, 1.000]
Elongation 0.999 [0.999, 1.000] 0.999 [0.998, 0.999] 0.995 [0.993, 0.997]
Flatness 1.000 [0.999, 1.000] 0.999 [0.999, 1.000] 0.992 [0.988, 0.995]
Volume density (AABB) 0.999 [0.998, 0.999] 0.989 [0.984, 0.993] 0.973 [0.959, 0.983]
Area density (AABB) 0.998 [0.997, 0.999] 0.989 [0.983, 0.993] 0.974 [0.961, 0.984]
Volume density (OMBB) NS NS NS
Area density (OMBB) NS NS NS
Volume density (AEE) 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 1.000 [1.000, 1.000]
Area density (AEE) 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 1.000 [1.000, 1.000]
Volume density (MVEE) NS NS NS
Area density (MVEE) NS NS NS
Volume density (convex hull) 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 1.000 [1.000, 1.000]
Area density (convex hull) 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 1.000 [1.000, 1.000]
Integrated intensity 0.942 [0.915, 0.963] 0.987 [0.980, 0.992] 0.981 [0.971, 0.988]
Moran's I index NA NA NA
Geary's C measure NA NA NA
Local intensity features
Local intensity peak 1.000 [1.000, 1.000] 0.967 [0.949, 0.980] 0.971 [0.955, 0.982]
Global intensity peak 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 1.000 [1.000, 1.000]
Intensity-based statistics features
Mean 0.999 [0.999, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Skewness 1.000 [1.000, 1.000] 0.997 [0.996, 0.998] 0.992 [0.988, 0.995]
(Excess) kurtosis 0.994 [0.992, 0.996] 0.997 [0.996, 0.998] 0.990 [0.986, 0.994]
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Median 0.998 [0.998, 0.999] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Minimum 0.990 [0.985, 0.994] 0.972 [0.958, 0.982] 0.983 [0.975, 0.989]
10th percentile 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.997 [0.996, 0.998]
90th percentile 0.999 [0.999, 1.000] 0.999 [0.999, 1.000] 0.998 [0.997, 0.999]
Maximum 0.998 [0.997, 0.999] 0.991 [0.986, 0.994] 0.993 [0.990, 0.996]
Interquartile range 0.999 [0.999, 0.999] 0.999 [0.999, 0.999] 0.996 [0.994, 0.997]
Range 0.994 [0.990, 0.996] 0.990 [0.986, 0.994] 0.990 [0.985, 0.994]
Mean absolute deviation 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Robust mean absolute deviation 1.000 [0.999, 1.000] 0.928 [0.895, 0.954] 0.995 [0.993, 0.997]
Median absolute deviation 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Coefficient of variation 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.997 [0.995, 0.998]
Quartile coefficient of dispersion 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.998 [0.997, 0.999]
Energy 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 1.000 [1.000, 1.000]
Root mean square 0.999 [0.998, 0.999] 0.999 [0.999, 0.999] 0.997 [0.995, 0.998]
Intensity histogram features
Mean 1.000 [0.999, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Skewness 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.998 [0.997, 0.999]
(Excess) kurtosis 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.998 [0.997, 0.999]
Median 1.000 [0.999, 1.000] 0.999 [0.999, 0.999] 0.997 [0.996, 0.998]
Minimum 0.992 [0.989, 0.995] 0.940 [0.912, 0.962] 0.984 [0.977, 0.990]
10th percentile 1.000 [1.000, 1.000] 0.996 [0.993, 0.997] 0.997 [0.995, 0.998]
90th percentile 0.977 [0.965, 0.985] 0.998 [0.996, 0.998] 0.993 [0.990, 0.996]
Maximum 0.996 [0.995, 0.998] 0.989 [0.984, 0.993] 0.993 [0.990, 0.996]
Mode 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 1.000 [0.999, 1.000]
Interquartile range 1.000 [1.000, 1.000] 0.997 [0.996, 0.998] 0.982 [0.973, 0.989]
Range 0.994 [0.991, 0.996] 0.990 [0.984, 0.993] 0.990 [0.985, 0.994]
Mean absolute deviation 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Robust mean absolute deviation 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.996 [0.993, 0.997]
Median absolute deviation 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.995, 0.998]
Coefficient of variation 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.997 [0.995, 0.998]
Quartile coefficient of dispersion 1.000 [1.000, 1.000] 0.981 [0.971, 0.988] 0.993 [0.990, 0.996]
Entropy 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.995 [0.993, 0.997]
Uniformity 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.996 [0.994, 0.997]
Maximum histogram gradient 1.000 [1.000, 1.000] 0.987 [0.981, 0.992] 0.999 [0.998, 0.999]
Maximum histogram gradient intensity 0.999 [0.999, 1.000] 0.897 [0.847, 0.934] 0.999 [0.999, 1.000]
Minimum histogram gradient 1.000 [1.000, 1.000] 0.992 [0.987, 0.995] 0.999 [0.999, 0.999]
Minimum histogram gradient intensity 0.999 [0.999, 0.999] 1.000 [1.000, 1.000] 0.999 [0.998, 0.999]
Intensity-volume histogram features
Volume fraction at 10% intensity 1.000 [1.000, 1.000] 0.989 [0.983, 0.994] 1.000 [1.000, 1.000]
Volume fraction at 90% intensity 0.882 [0.829, 0.923] 0.830 [0.760, 0.889] 0.872 [0.816, 0.917]
Intensity at 10% volume 0.999 [0.999, 1.000] 0.999 [0.999, 0.999] 0.998 [0.997, 0.999]
Intensity at 90% volume 1.000 [1.000, 1.000] 0.995 [0.992, 0.997] 1.000 [1.000, 1.000]
Volume fraction difference between 10% and 90% 
intensity
1.000 [1.000, 1.000] 0.985 [0.978, 0.991] 1.000 [1.000, 1.000]
Intensity difference between 10% and 90% volume 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.997 [0.996, 0.998]
Area under the IVH curve NS NS NS
Co-occurrence matrix features
Joint maximum 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.996, 0.998]
Joint average 0.999 [0.999, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
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Joint variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.995, 0.998]
Joint entropy 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.997]
Difference average 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.996 [0.995, 0.998]
Difference variance 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.998 [0.996, 0.998]
Difference entropy 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.997 [0.995, 0.998]
Sum average 0.999 [0.999, 1.000] 0.999 [0.999, 0.999] 0.997 [0.995, 0.998]
Sum variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Sum entropy 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.993, 0.997]
Angular second moment 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.995 [0.992, 0.997]
Contrast 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.996, 0.998]
Dissimilarity 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.996 [0.995, 0.998]
Inverse difference 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.998 [0.996, 0.998]
Normalized inverse difference 0.999 [0.998, 0.999] 0.975 [0.963, 0.984] 0.996 [0.994, 0.998]
Inverse difference moment 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.998 [0.996, 0.999]
Normalized inverse difference moment 0.997 [0.995, 0.998] 0.969 [0.955, 0.981] 0.994 [0.991, 0.996]
Inverse variance 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.994 [0.992, 0.997]
Correlation 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.995 [0.992, 0.997]
Autocorrelation 0.999 [0.999, 1.000] 0.999 [0.999, 0.999] 0.997 [0.995, 0.998]
Cluster tendency 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Cluster shade 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.994, 0.997]
Cluster prominence 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Information correlation 1 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.997 [0.996, 0.998]
Information correlation 2 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.999 [0.998, 0.999]
Run length matrix features
Short runs emphasis 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.997 [0.996, 0.998]
Long runs emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.998 [0.998, 0.999]
Low grey level run emphasis 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.999 [0.998, 0.999]
High grey level run emphasis 0.999 [0.999, 1.000] 0.999 [0.999, 0.999] 0.996 [0.995, 0.998]
Short run low grey level emphasis 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.999 [0.998, 0.999]
Short run high grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.997 [0.995, 0.998]
Long run low grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.998 [0.997, 0.999]
Long run high grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 0.999] 0.994 [0.991, 0.996]
Grey level non-uniformity 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.999 [0.998, 0.999]
Normalized grey level non-uniformity 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.996 [0.993, 0.997]
Run length non-uniformity 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.993 [0.990, 0.996]
Normalized run length non-uniformity 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.998 [0.996, 0.998]
Run percentage 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.998 [0.997, 0.999]
Grey level variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Run length variance 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.999 [0.998, 0.999]
Run entropy 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.995 [0.992, 0.997]
Size zone matrix features
Small zone emphasis 0.998 [0.997, 0.999] 0.962 [0.944, 0.976] 0.979 [0.968, 0.987]
Large zone emphasis 0.999 [0.999, 1.000] 0.999 [0.998, 0.999] 0.986 [0.979, 0.991]
Low grey level emphasis 1.000 [1.000, 1.000] 0.992 [0.988, 0.995] 0.999 [0.998, 0.999]
High grey level emphasis 0.999 [0.999, 1.000] 0.999 [0.998, 0.999] 0.996 [0.993, 0.997]
Small zone low grey level emphasis 1.000 [1.000, 1.000] 0.977 [0.965, 0.985] 0.995 [0.992, 0.997]
Small zone high grey level emphasis 0.999 [0.999, 0.999] 0.995 [0.992, 0.997] 0.999 [0.998, 0.999]
Large zone low grey level emphasis 0.998 [0.997, 0.999] 0.999 [0.998, 0.999] 0.992 [0.988, 0.995]
Large zone high grey level emphasis 0.999 [0.998, 0.999] 0.998 [0.997, 0.999] 0.975 [0.963, 0.984]
Grey level non-uniformity 0.997 [0.996, 0.998] 0.998 [0.996, 0.999] 0.920 [0.882, 0.949]
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Normalized grey level non-uniformity 0.999 [0.999, 0.999] 0.995 [0.993, 0.997] 0.994 [0.991, 0.996]
Zone size non-uniformity 0.998 [0.997, 0.999] 0.996 [0.995, 0.998] 0.944 [0.919, 0.964]
Normalized zone size non-uniformity 0.998 [0.997, 0.999] 0.971 [0.957, 0.982] 0.973 [0.959, 0.983]
Zone percentage 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.993 [0.989, 0.995]
Grey level variance 0.998 [0.998, 0.999] 0.998 [0.997, 0.999] 0.996 [0.993, 0.997]
Zone size variance 0.999 [0.999, 1.000] 0.999 [0.998, 0.999] 0.986 [0.979, 0.991]
Zone size entropy 0.998 [0.997, 0.999] 0.991 [0.986, 0.994] 0.938 [0.909, 0.960]
Distance zone matrix features
Small distance emphasis 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.994 [0.991, 0.996]
Large distance emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.999 [0.998, 0.999]
Low grey level emphasis 1.000 [1.000, 1.000] 0.996 [0.995, 0.998] 1.000 [1.000, 1.000]
High grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.996 [0.993, 0.997]
Small distance low grey level emphasis 1.000 [1.000, 1.000] 0.996 [0.994, 0.997] 1.000 [1.000, 1.000]
Small distance high grey level emphasis 1.000 [0.999, 1.000] 0.999 [0.998, 0.999] 0.999 [0.998, 0.999]
Large distance low grey level emphasis 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 1.000 [0.999, 1.000]
Large distance high grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.998 [0.997, 0.999]
Grey level non-uniformity 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.997 [0.996, 0.998]
Normalized grey level non-uniformity 1.000 [1.000, 1.000] 0.998 [0.998, 0.999] 0.995 [0.993, 0.997]
Zone distance non-uniformity 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.995 [0.993, 0.997]
Normalized zone distance non-uniformity 1.000 [1.000, 1.000] 0.998 [0.997, 0.999] 0.995 [0.992, 0.997]
Zone percentage 1.000 [1.000, 1.000] 0.999 [0.999, 1.000] 0.997 [0.995, 0.998]
Grey level variance 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.996 [0.994, 0.998]
Zone distance variance 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.999 [0.999, 0.999]
Zone distance entropy 1.000 [1.000, 1.000] 1.000 [0.999, 1.000] 0.992 [0.988, 0.995]
Neighborhood grey tone difference matrix features
Coarseness 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 0.997 [0.995, 0.998]
Contrast 0.999 [0.998, 0.999] 1.000 [1.000, 1.000] 0.999 [0.999, 0.999]
Busyness 0.999 [0.998, 0.999] 0.999 [0.998, 0.999] 1.000 [0.999, 1.000]
Complexity 0.998 [0.997, 0.999] 0.998 [0.998, 0.999] 0.997 [0.996, 0.998]
Strength 0.999 [0.998, 0.999] 0.999 [0.998, 0.999] 0.999 [0.998, 0.999]
Neighboring grey level dependence matrix features
Low dependence emphasis 1.000 [0.999, 1.000] 0.998 [0.997, 0.999] 0.993 [0.990, 0.996]
High dependence emphasis 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.999 [0.998, 0.999]
Low grey level count emphasis 0.993 [0.989, 0.995] 0.999 [0.999, 1.000] 0.982 [0.973, 0.989]
High grey level count emphasis 0.996 [0.994, 0.997] 0.999 [0.999, 0.999] 0.979 [0.969, 0.987]
Low dependence low grey level emphasis 1.000 [1.000, 1.000] 0.989 [0.984, 0.993] 0.990 [0.985, 0.994]
Low dependence high grey level emphasis 1.000 [1.000, 1.000] 0.999 [0.998, 0.999] 0.997 [0.995, 0.998]
High dependence low grey level emphasis 0.999 [0.999, 1.000] 0.999 [0.998, 0.999] 0.993 [0.990, 0.996]
High dependence high grey level emphasis 0.999 [0.999, 1.000] 0.997 [0.995, 0.998] 0.978 [0.967, 0.986]
Grey level non-uniformity 0.991 [0.986, 0.994] 0.999 [0.999, 1.000] 0.950 [0.927, 0.968]
Normalized grey level non-uniformity 0.998 [0.997, 0.999] 1.000 [0.999, 1.000] 0.971 [0.957, 0.981]
Dependence count non-uniformity 0.986 [0.979, 0.991] 0.999 [0.999, 1.000] 0.885 [0.836, 0.925]
Normalized dependence count non-uniformity 1.000 [1.000, 1.000] 0.998 [0.996, 0.998] 0.992 [0.988, 0.995]
Dependence count percentage 1.000 [1.000, 1.000] 1.000 [1.000, 1.000] 1.000 [1.000, 1.000]
Grey level variance 0.998 [0.997, 0.999] 0.999 [0.999, 1.000] 0.996 [0.994, 0.998]
Dependence count variance 1.000 [1.000, 1.000] 0.992 [0.988, 0.995] 0.994 [0.992, 0.996]
Dependence count entropy 0.997 [0.995, 0.998] 0.997 [0.996, 0.998] 0.964 [0.947, 0.977]
Dependence count energy 0.997 [0.995, 0.998] 0.997 [0.995, 0.998] 0.971 [0.957, 0.982]
Page 61 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d v
ers
ion
 2
20
- 1
-07
29
Table N10: Reproducibility of standardized features on the validation cohort, organized by feature and 
modality. A two-way random effects, single rater, absolute agreement intraclass correlation coefficient 
(ICC) and its 95% confidence interval were used to assess reproducibility. NA: the feature was 
standardized but values were computed by less than two team; NS: the feature was not standardized.
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Supplementary note L: Causes of deviations
We identified several causes of deviations from the reference values for standardized features, 
including:
● The image interpolation grid required careful definition (see IBSI reference manual sections 
2.4 and 5.2.1) to make radiomics features in phase II reproducible.
● Interpolation was sometimes conducted at half precision (16-bit), which led to deviations in 
interpolated intensities.
● The absence of mesh-based volume representation caused associated morphological 
features to deviate noticeably for smaller regions of interest, such as the digital phantom (see 
section 3.1 of the IBSI reference manual). This was mostly because surface area would be 
computed in different ways.
● Inconsistent use of distance units (e.g. cm instead of mm). This was an issue for 
morphological features that are not dimensionless.
● The indexation of the rows and columns in texture matrices needed to be consistent and 
include rows and columns that only contain zero-valued elements. For example, intensities 2 
and 5 are missing in the digital phantom. Dropping associated rows or columns from a texture 
matrix is incorrect and caused deviations.
● In the early stages, names of contributed features were occasionally difficult to match to the 
same feature definition, which was also reported previously (17–19). We recommend using 
names and nomenclature presented in the IBSI reference manual.
● Prior to the definition of morphological and intensity ROI masks, intensity-based re-
segmentation of the ROI mask would lead to deviations. Some teams attempted to close 
small holes prior to computing morphological features, whereas others would leave them as 
is.
● Intensity-histogram entropy was sometimes computed directly from the image intensities, 
without binning.
● Neighbourhood grey tone difference matrix based features busyness, complexity and strength 
were sometimes computed without excluding discretized grey level probabilities equal to zero.
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1IBSI guidelines for reporting on
radiomics studies
Checklist - Version 1.0 (October 2019)
This checklist focuses specifically on in-depth reporting of studies involving radiomics. Other reporting 
guidelines may be applicable as well, e.g. STROBE (observational studies), CONSORT (randomised 
trials).
Not all items may be applicable. Indicate only applicable items.
Topic Item Description Page
Patient
Region of interest1 1 Describe the region of interest that is being imaged.
Patient preparation 2a Describe specific instructions given to patients prior to 
image acquisition, e.g. fasting prior to imaging.
2b Describe administration of drugs to the patient prior to image 
acquisition, e.g. muscle relaxants.
2c Describe the use of specific equipment for patient comfort 
during scanning, e.g. ear plugs.
Radioactive tracer PET, SPECT 3a Describe which radioactive tracer was administered to the 
patient, e.g. 18F-FDG.
PET, SPECT 3b Describe the administration method.
PET, SPECT 3c Describe the injected activity of the radioactive tracer at 
administration.
PET, SPECT 3d Describe the uptake time prior to image acquisition.
PET, SPECT 3e Describe how competing substance levels were  controlled.2
Contrast agent 4a Describe which contrast agent was administered to the 
patient.
4b Describe the administration method.
4c Describe the injected quantity of contrast agent.
4d Describe the uptake time prior to image acquisition.
4e Describe how competing substance levels were controlled.
Comorbidities 5 Describe if the patients have comorbidities that affect 
imaging.3
Acquisition4
Acquisition protocol 6 Describe whether a standard imaging protocol was used, 
and where its description may be found.
Scanner type 7 Describe the scanner type(s) and vendor(s) used in the 
study.
Imaging modality 8 Clearly state the imaging modality that was used in the 
study, e.g. CT, MRI.
Static/dynamic scans 9a State if the scans were static or dynamic.
1 Also referred to as volume of interest.
2 An example is glucose present in the blood which competes with the uptake of 18F-FDG tracer in tumour tissue. To reduce 
competition with the tracer, patients are usually asked to fast for several hours and a blood glucose measurement may be 
conducted prior to tracer administration.
3 An example of a comorbidity that may affect image quality in 18F-FDG PET scans are type I and type II diabetes melitus, as 
well as kidney failure.
4 Many acquisition parameters may be extracted from DICOM header meta-data, or calculated from them.
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2Dynamic scans 9b Describe the acquisition time per time frame.
Dynamic scans 9c Describe any temporal modelling technique that was used.
Scanner calibration 10 Describe how and when the scanner was calibrated.
Patient instructions 11 Describe specific instructions given to the patient during 
acquisition, e.g. breath holding.
Anatomical motion 
correction
12 Describe the method used to minimise the effect of 
anatomical motion.
Scan duration 13 Describe the duration of the complete scan or the time per 
bed position.
Tube voltage CT 14 Describe the peak kilo voltage output of the X-ray source.
Tube current CT 15 Describe the tube current in mA.
Time-of-flight PET 16 State if scanner time-of-flight capabilities are used during 
acquisition.
RF coil MRI 17 Describe what kind RF coil used for acquisition, incl. vendor.
Scanning sequence MRI 18a Describe which scanning sequence was acquired.
MRI 18b Describe which sequence variant was acquired.
MRI 18c Describe which scan options apply to the current sequence, 
e.g. flow compensation, cardiac gating.
Repetition time MRI 19 Describe the time in ms between subsequent pulse 
sequences.
Echo time MRI 20 Describe the echo time in ms.
Echo train length MRI 21 Describe the number of lines in k-space that are acquired 
per excitation pulse.
Inversion time MRI 22 Describe the time in ms between the middle of the inverting 
RF pulse to the middle of the excitation pulse.
Flip angle MRI 23 Describe the flip angle produced by the RF pulses.
Acquisition type MRI 24 Describe the acquisition type of the MRI scan, e.g. 3D.
k-space traversal MRI 25 Describe the acquisition trajectory of the k-space.
Number of averages/ 
excitations
MRI 26 Describe the number of times each point in k-space is 
sampled.
Magnetic field strength MRI 27 Describe the nominal strength of the MR magnetic field.
Reconstruction5
In-plane resolution 28 Describe the distance between pixels, or alternatively the 
field of view and matrix size.
Image slice thickness 29 Describe the slice thickness.
Image slice spacing 30 Describe the distance between image slices.6
Convolution kernel CT 31a Describe the convolution kernel used to reconstruct the 
image.
CT 31b Describe settings pertaining to iterative reconstruction 
algorithms.
Exposure CT 31c Describe the exposure (in mAs) in slices containing the 
region of interest.
Reconstruction method PET 32a Describe which reconstruction method was used, e.g. 3D 
OSEM.
PET 32b Describe the number of iterations for iterative reconstruction.
PET 32c Describe the number of subsets for iterative reconstruction.
Point spread function 
modelling
PET 33 Describe if and how point-spread function modelling was 
performed.
Image corrections PET 34a Describe if and how attenuation correction was performed.
PET 34b Describe if and how other forms of correction were 
performed, e.g. scatter correction, randoms correction, dead 
time correction etc.
5 Many reconstruction parameters may be extracted from DICOM header meta-data.
6 Spacing between image slicing is commonly, but not necessarily, the same as the slice thickness,.
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3Reconstruction method MRI 35a Describe the reconstruction method used to reconstruct the 
image from the k-space information.
MRI 35b Describe any artifact suppression methods used during 
reconstruction to suppress artifacts due to undersampling of 
k-space.
Diffusion-weighted 
imaging
DWI-MRI 36 Describe the b-values used for diffusion-weighting.
Image registration
Registration method 37 Describe the method used to register multi-modality 
imaging.
Image processing - data conversion
SUV normalisation PET 38 Describe which standardised uptake value (SUV) 
normalisation method is used.
ADC computation DWI-MRI 39 Describe how apparent diffusion coefficient (ADC) values 
were calculated.
Other data conversions 40 Describe any other conversions that are performed to 
generate e.g. perfusion maps.
Image processing - post-acquisition processing
Anti-aliasing 41 Describe the method used to deal with anti-aliasing when 
down-sampling during interpolation.
Noise suppression 42 Describe methods used to suppress image noise.
Post-reconstruction 
smoothing filter
PET 43 Describe the width of the Gaussian filter (FWHM) to spatially 
smooth intensities.
Skull stripping MRI (brain) 44 Describe method used to perform skull stripping.
Non-uniformity 
correction7
MRI 45 Describe the method and settings used to perform non-
uniformity correction.
Intensity normalisation 46 Describe the method and settings used to normalise 
intensity distributions within a patient or patient cohort.
Other post-acquisition 
processing methods
47 Describe any other methods that were used to process the 
image and are not mentioned separately in this list.
Segmentation
Segmentation method 48a Describe how regions of interest were segmented, e.g. 
manually.
48b Describe the number of experts, their expertise and 
consensus strategies for manual delineation.
48c Describe methods and settings used for semi-automatic and 
fully automatic segmentation.
48d Describe which image was used to define segmentation in 
case of multi-modality imaging.
Conversion to mask 49 Describe the method used to convert polygonal or mesh-
based segmentations to a voxel-based mask.
Image processing - image interpolation
Interpolation method 50a Describe which interpolation algorithm was used to 
interpolate the image.
50b Describe how the position of the interpolation grid was 
defined, e.g. align by center.
50c Describe how the dimensions of the interpolation grid were 
defined, e.g. rounded to nearest integer.
50d Describe how extrapolation beyond the original image was 
handled.
Voxel dimensions 51 Describe the size of the interpolated voxels.
Intensity rounding CT 52 Describe how fractional Hounsfield Units are rounded to 
integer values after interpolation.
Image processing - ROI interpolation
7 Also known as bias-field correction.
Page 68 of 70
10 E. Doty St., Suite 441, Madison, WI 53703, 630-481-1047, radiology@rsna.org
RADIOLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d v
rsi
n 2
02
0-0
1-0
7
4Interpolation method 53 Describe which interpolation algorithm was used to 
interpolate the region of interest mask.
Partially masked voxels 54 Describe how partially masked voxels after interpolation are 
handled.
Image processing - re-segmentation
Re-segmentation 
methods
55 Describe which methods and settings are used to re-
segment the ROI intensity mask.
Image processing - discretisation
Discretisation method8 56a Describe the method used to discretise image intensities.
56b Describe the number of bins (FBN) or the bin size (FBS) 
used for discretisation.
56c Describe the lowest intensity in the first bin for FBS 
discretisation.9
Image processing - image transformation
Image filter10 57 Describe the methods and settings used to filter images, 
e.g. Laplacian-of-Gaussian.
Radiomics feature computation
Feature set 58 Describe which set of radiomics features is computed and 
refer to their definitions or provide these.
IBSI compliance 59 State if the software used to extract the set of features is 
able to reproduce the IBSI feature reference values.11
Robustness 60 Describe how robustness of the features was assessed, e.g. 
test-retest analysis.
Software availability 61 Describe which software and version was used to compute 
features.
Radiomics feature computation - texture parameters
Texture matrix 
aggregation
62 Define how texture-matrix based features were computed 
from underlying texture matrices.
Distance weighting 63 Define how CM, RLM, NGTDM and NGLDM weight 
distances, e.g. no weighting.
CM symmetry 64 Define whether symmetric or asymmetric co-occurrence 
matrices were computed.
CM distance 65 Define the (Chebyshev) distance at which co-occurrence of 
intensities is determined, e.g. 1.
SZM linkage distance 66 Define the distance and distance norm for which voxels with 
the same intensity are considered to belong to the same 
zone for the purpose of constructing an SZM, e.g. 
Chebyshev distance of 1.
DZM linkage distance 67 Define the distance and distance norm for which voxels with 
the same intensity are considered to belong to the same 
zone for the purpose of constructing a DZM, e.g. Chebyshev 
distance of 1.
DZM zone distance 
norm
68 Define the distance norm for determining the distance of 
zones to the border of the ROI, e.g. Manhattan distance.
NGTDM distance 69 Define the neighbourhood distance and distance norm for 
the NGTDM, e.g. Chebyshev distance of 1.
NGLDM distance 70 Define the neighbourhood distance and distance norm for 
the NGLDM, e.g. Chebyshev distance of 1.
NGLDM coarseness 71 Define the coarseness parameter for the NGLDM, e.g. 0.
8 Discretisation may be performed separately to create intensity-volume histograms. If this is indeed the case, this should be 
described as well.
9 This is typically set by range re-segmentation.
10 The IBSI has not introduced image transformation into the standardised image processing scheme, and is in the process of 
benchmarking various common filters. This section may therefore be expanded in the future.
11 A software is compliant if and only if it is able to reproduce the feature reference values for the digital phantom and for one or 
more image processing configurations using the radiomics CT phantom. Reviewers may demand that you provide the IBSI 
compliance spreadsheet for your software.
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5Machine learning and radiomics analysis
Diagnostic and 
prognostic modelling
72 See the TRIPOD guidelines for reporting on diagnostic and 
prognostic modelling.
Comparison with known 
factors
73 Describe where performance of radiomics models is 
compared with known (clinical) factors.
Multicollinearity 74 Describe where the multicollinearity between radiomics 
features in the signature is assessed.
Model availability 75 Describe where radiomics models with the necessary pre-
processing information may be found.
Data availability 76 Describe where imaging data and relevant meta-data used 
in the study may be found.
The reporting guidelines presented above are a copy of the guidelines found in section 4.1 of 
the IBSI reference manual (see online supplemental materials).
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